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Abstract
Explosive materials are increasingly being exploited by criminal organisations,
with harmful, devastating and destructive effects on targeted societies; highlight-
ing the demand for sensitive, reliable and quick explosive detection methods that
can be used in a range of environments. Immunoassays are one type of test that
can provide these qualities. Immunoassays use antibodies to detect a molecule of
interest (analyte). A common type of user-friendly immunoassay that has been
employed for a wide-range of applications is the lateral flow immunoassay (LFIA).
A LFIA simplifies the immunoassay procedure, applying the principle (discussed
in detail later) to perform along a single axis by utilising a porous membrane.
This type of test is quick, sensitive and relatively easy to use, which means it
is accessible by non-specialised personnel. This research uses a competitive im-
munoassay format, which arises from competitive binding between a free form and
a bound form of the analyte. Successful detection of explosive material: 2,4,6-
trinitrotoluene (TNT) has been demonstrated via a competitive immunoassay
technique. Through optimisation of reagents and conditions, the limit of detec-
tion is 0.03 µg ml-1 (300 pg per fingerprint deposit) on a plate assay format. Initial
steps have been taken to apply this mechanism to the LFIA format to produce
a test. However, further research is required before a functioning device is ready
for commercial value.
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Chapter 1
Introduction
The aim of the research described in this thesis was to detect explosive materi-
als in fingerprints with a competitive immunoassay technique. This chapter will
begin with a description of the formation and composition of fingerprints. Next,
the classification of explosive materials will be discussed, looking at the current
techniques being developed to detect explosive materials in fingerprints. The final
part of this chapter will focus on the competitive fluoroimmunoassay technique
used in this research, with a description of fluorescence.
1.1 Fingerprints
Fingerprints have vast potential in forensic analysis as they are thought to be
unique to an individual [1]. Fingerprints are therefore a valuable tool for linking
identification to criminal activity, whether that be locating an individual to a
crime or detecting an illegal substance handled or metabolised by an individual.
1.1.1 Fingerprint Formation
Fingerprints are impressions of a friction ridge pattern located on the fingertips,
formed from sweat secretions that are deposited upon contact with a surface [2].
The friction ridge pattern is a thickened layer of skin which begins development
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in the womb. It is both genetically and environmentally influenced by factors,
such as the fetus’ position within the womb [1]. This results in even identical
twins, who share the same DNA, having differing fingerprints [3]. The friction
ridge pattern begins development in the womb at around seven to ten weeks. By
the nineteenth week, the pattern becomes permanent, unchanging throughout an
individual’s life [4]. The friction ridge skin covers the surface of the palms, fingers,
soles and toes. It forms a complex pattern involving arches, loops and whorls as
seen in Figure 1.1 [5]. Although other patterns do occur, they are more rare. As
demonstrated in Kücken and Newell [1], loops can be classified by an arch, which
opens towards the thumb or the finger. The former is given the term radial and
the latter is termed ulnar. Loops are accompanied by one triradius, which is the
meeting of three ridge patterns at 120o. A whorl pattern consists of a spiral with
the addition of two triradii [1]. Defects in the patterns are referred to as minutiae [6]
and can consist of dislocations, islands and incipient ridges [1]. There can be up to
70 minutiae per fingerprint [7]. It is the minutiae in the patterns that are exclusive
to an individual, which allows for discrimination between different fingerprints for
identification purposes [1].
a) b) c)
Figure 1.1: Fingertip ridge patterns: a) arch; b) loop; and c) whorl. Image from
Kahn [8].
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1.1.2 Fingerprint Composition
As well as identifying an individual through fingerprints, it is also possible to
detect substances ingested or handled through the fingerprint depositions. As
stated previously, fingerprint deposits are composed of an individual’s sweat se-
cretions. The sweat is secreted from pores within the fingertip ridges. There are
three main types of sweat secreted from the body, which include eccrine, apocrine
and sebaceous. Each type of sweat has a different composition and is secreted in
varying locations. The eccrine glands are concentrated in the hands and feet, al-
though they can be found in most parts of the body. Eccrine sweat is composed of
~98% water, where the remaining ~2% is composed of both organic ( e.g., amino
acids, lipids, glucose) and inorganic (e.g., chloride, iron, calcium) components [2].
The apocrine glands are present from birth but do not become activated until
puberty. They are primarily located in the axilla and genital areas of the body [9].
The sebaceous glands are located all over the body, apart from the hands and
feet [10]. Sebaceous sweat is called sebum, which is a waxy substance that helps
waterproof, as well as hydrate, the skin [11]. The sebum is mainly composed of
lipids, lipid esters and sterols [2].
As fingertip ridges are lined with eccrine sweat pores, deposited fingerprints are
mainly composed of eccrine secretions. Fingerprints often contain varying levels
of sebaceous secretions from contact of the hands with the hair and face; as well as
excreted metabolites from the body, and contaminants that the hands have come
into contact with [2]. Fingerprint composition can also vary dependent on fac-
tors such as diet/contaminants [12], gender [13], age [14], and contact pressure/time
of fingerprint deposition [15]. Therefore, fingerprints are useful for identification
purposes as well as detecting substances that an individual has ingested (from
excreted metabolites) or handled.
The ability to detect suspicious contaminants in fingerprints provides a non-
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invasive method to link a handled substance with the identification of a handler.
There have already been methods demonstrated that detect drugs of abuse in
fingerprint deposits [16]. However, there is a pressing need to be able to detect ex-
plosive materials due to criminal activity that exploits explosive substances. The
strong advantage of being able to detect explosive materials in fingerprints is that
it offers a method to identify those who have handled explosive substances, in the
hope of preventing catastrophic and devastating events from occurring.
1.2 Explosive Materials
1.2.1 Classification of Explosives
Explosive materials are energetic molecules that rapidly decompose through a
self-propagation mechanism upon initiation by stimuli, such as sparks and fric-
tion [17]. This process results in the sudden release of heat and gases as more stable
products are formed [18]. The blast is the build up of pressure that occurs when
large quantities of gas are produced which require a much bigger volume than the
starting material [19]. Explosive materials can detonate or deflagrate depending on
the strength of the shock wave generated by the ignition source [19].
Explosive materials are commonly classified by their characteristics. Firstly, they
can be divided by their burn rates into high (~km s-1) or low explosives (~cm s-1).
High explosives are further categorised by their stability into primary, secondary
and tertiary explosives, with primary explosives being the most sensitive to initi-
ation. Low explosives are composed of propellants and pyrotechnics. Propellants
are used to propel or accelerate compounds in rockets and guns, for example
gunpowder [20]. Pyrotechnics, like all explosive materials, undergo exothermic re-
actions and release heat, light, sound and gas. Common uses of pyrotechnics are
for fireworks, flares and matches [21]. Explosives can also be classified by their
chemical structure. The majority of explosives fall into one of the categories
4
of nitroaromatics, nitroamines, nitrate esters, peroxides or acid salts. Table 1.1
summarises these properties of common explosives. Note that high explosives
detonate, whereas low explosives deflagrate. The explosive material that was the
focus of this research is 2,4,6-trinitrotoluene (TNT), a high explosive.
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1.2.2 TNT
The nitroaromatic molecule: TNT, is a secondary high explosive. The structure
is shown in Figure 1.2. It has a low molecular weight of 227.13 g mol-1 and
relatively low solubility in water of 130 mg L-1. TNT was originally used as a
yellow dye for industrial applications, since 1863. Its explosive properties were
not discovered until 1891 by Carl Haeussermann, primarily due to its insensitivity
to detonation [22]. However, it is now the most commonly used explosive in the
military. This is because of its insensitivity and low melting temperature (83oC).
This allows for a molten solution to be poured for ammunition production. TNT
is also highly toxic to a diverse range of organisms, and an environmental contam-
inant. TNT is toxic to humans via inhalation, ingestion and absorption through
the skin. It is metabolised by the liver, primarily into: 2-amino-4,6-dinitrotoluene
and 4-amino-2,6-dinitrotoluene. Exposure to TNT has resulted in many adverse
health effects, including anaemia, headaches, nausea and liver disease, as well as
damaging effects to reproductive functioning [23]. TNT is also suspected to be a
carcinogen [24].
Figure 1.2: The structure of TNT.
1.2.3 Current Detection Methods of Explosives in Finger-
prints
The criminal use of explosive materials may involve a variety of substances [25].
This requires detection methods to be able to differentiate between a wide range
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of explosive materials with high sensitivity, as there are often only trace levels of
tested residue. The use of latent fingerprints for the detection of explosive ma-
terial can identify trace levels of substance as well as the handler. This link is
critical for determining responsibility for a criminal activity, and is not provided
by many other techniques. However, latent fingerprints are invisible to the naked
eye, and require treatment for visualisation and detection of substances. With
this in mind, detection of explosives in latent fingerprints has been explored using
many different methods. An ideal detection method would be quick, low-cost,
non-invasive, non-destructive to the print, transportable, and exhibit high sen-
sitivity and reliability. The need for these techniques to be highly sensitive is
emphasised by the variability in quantity and distribution of material between
different fingerprints [26] [27]. If these techniques will be used for prosecution appli-
cations, reliability and accuracy are essential.
Mass Spectrometry
Mass spectrometry (MS) is a technique which measures the mass-to-charge ratio
and relative abundance of ions [28]. Briefly, MS requires a sample to be ionised; a
mass analyser to separate the species according to their mass-to-charge ratio; and
a detector that converts the energy from the incoming particles into a signal that
can be interpreted by a computer of the spectrometer. There are many variations
of the MS technique, with different ion sources, mass analysers and detectors avail-
able. The different MS methods have their own strengths and weaknesses, but all
provide a large amount of chemical information along with high chemical sensitiv-
ity. This has resulted in different types of MS being used for explosive detection in
fingerprints [29], including: desorption electrospray ionization (DESI); direct analy-
sis in real time-MS (DART-MS); and surface-assisted laser desorption/ionization-
time of flight-MS (SALDI-TOF-MS). In 2008, Ifa et al. [29] used DESI to detect
RDX in a deposited fingerprint, whilst also providing an image of the fingerprint.
The results were obtained, with images having a resolution of 150 µm , i.e., one
pixel corresponds to a 150 µm by 150 µm area of the sample. The conditions pro-
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vided a limit of detection at 5 µg of RDX. In 2012, Rowell et al. [30] performed
a comparative study between DART-MS and SALDI-TOF-MS for the detection
of explosive contaminants in lifted and non-lifted fingerprints. A range of explo-
sive materials were tested, including TNT, RDX, PETN, HMX, TATP, TNG and
Tetryl. A novel approach was taken to locate and enhance the explosive mate-
rials in the fingerprints by applying magnetisable-doped silica-based sub-micron
particles. The particles were added after dusting the prints and then lifted with
tape, ready for analysis. In non-lifted fingerprints, both DART-MS and SALDI-
TOF-MS successfully detected the explosive contaminants in the prints, with a
detection limit of 10-100 ng. However, only SALDI-TOF-MS could detect the
explosive residues in the lifted fingerprints. This was due to the high background
level from the tape that prevented substance discrimination. Clemons et al. [31]
used a DART-MS method in conjunction with direct analyte-probed nanoextrac-
tion (DAPNe-DART-MS). This was used to detect the explosive materials TNT
and RDX at a sample particle size of ~20 µm . Hence, this method provided
sensitive analysis whilst keeping the fingerprint intact. One of the most sensitive
techniques for material determination is mass spectrometry (MS) coupled with gas
chromatography (GC-MS) [32]. However, GC-MS, as well as most types of MS, is
a difficult technique to apply to security environments as they are expensive, not
portable and often require trained personnel to operate the equipment.
Ion Mobility Spectrometry
Ion mobility spectrometry (IMS) is the most widespread technique employed for
explosive residue detection in airports [33]. A range of handheld IMS devices al-
ready exist, for example Quantum Sniffer QS-H150 (Implant Sciences Corpora-
tion), MicroHound (Sandia National Laboratories) and Mobile Trace (Morpho
Detection) [34]. Developments in IMS have resulted in the technique having strong
advantages, including rapid data acquisition, high sensitivity and portability. In
2014, Staymates et al. [35] demonstrated detection of RDX in lifted fingerprints us-
ing IMS. This novel technique also has the advantage of ensuring the fingerprint
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was kept intact for imaging and identification. Although, improvements on the
solution used to lift the fingerprints is necessary to reduce background signal for
increased discrimination between materials. Although IMS has its advantages, it
can be difficult to quantify the results and false positives can be observed from
contaminants or other molecules within the sample matrix [36].
Vibrational Spectroscopy
Vibrational spectroscopy measures the vibrational energy levels associated with
the chemical bonds in the structure. Molecules contain different vibrational mo-
tions, or modes, that can be affected by a number of different factors, includ-
ing atom and bond orientation, atomic mass, bond order and hydrogen bonds.
The patterns of vibrations relate to molecular symmetry, molecular shape, and
strength of each bond. Hence, vibrational spectroscopy can provide large amounts
of chemical information. The main types of analytical techniques that use vibra-
tional spectroscopy are Infrared spectroscopy (IR) and Raman spectroscopy.
IR is the most commonly used of the two techniques. For a molecule to be
IR active, the molecule must exhibit a change in molecular dipole moment dur-
ing vibration [37]. Primarily, molecules with non-polar bonds and non-symmetric
vibrations are detected with IR. Generally, IR involves a sample being irradiated
with radiation from the IR region of the electromagnetic spectrum. The molecules
within a substance absorb wavelengths of light whose energies correspond to par-
ticular molecular vibrations within the molecule. The different absorbance inten-
sities at different wavelengths of light are measured to provide a characteristic
IR spectrum for a given molecule. This is known as a molecule’s "fingerprint"
region, as the absorbance pattern is unique to a molecule. Like most spectroscopy
techniques, there are variations in the methods and each with their own strengths
and weaknesses. In 2014, Fernández de la Ossa et al. [38] used near infrared hy-
perspectral imaging (NIR-HSI) technique to detect numerous explosive materials
(ammonium nitrate, dynamite, blackpowder, single-base and double-base smoke-
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less gun powder) in fingerprints. The method had a quick analysis time, preserved
the fingerprint integrity, and also didn’t require sample preparation. However,
the small test area could prove problematic and the sensitivity still required in-
vestigation. In the same year, Fernández de la Ossa et al. [39] also demonstrated
NIR-HSI to detect dynamite and ammonium nitrate. This technique provided
100% specificity with a spatial detection limit of 300 µm . Another type of IR
is Fourier transformation-IR (FT-IR), which can have improved sensitivity and
reduced measurement time compared to IR, as all IR wavelengths are measured
simultaneously [40]. The intensities are interpreted by a mathematical technique
called the Fourier transformation, processed by a computer linked to the spec-
trometer. Bhargava et al. [41] employed a FTIR spectroscopic imaging technique,
which is neither invasive nor destructive of the latent fingerprint. Detection of the
explosive material (RDX) was demonstrated along with an imaged and preserved
fingerprint. Chen et al. [42] also demonstrated detection of RDX (~0.1 ng pixel-1)
within contaminated fingerprint deposits using FTIR imaging. FTIR does not
require sample preparation, which maintains the integrity of the fingerprint. The
prints are high enough quality to be used for matching in databases. Mou and
Rabalais [43] demonstrate a technique that couples an attenuated total reflection
microscope to FTIR (ATR-FTIR) for the detection of TNT, TNB and ammonium
nitrate. This method allowed for the discrimination between fingerprint and ex-
plosive residue, as small as 20 µm . This technique is also non-invasive.
In Raman spectroscopy, a molecule must exhibit a change in its polarisability
to be Raman active. This involves an alteration in the size, shape or orientation
of the electron cloud that surrounds the molecule. A sample is irradiated with
visible light where the molecules then absorb and reemit. Some of this energy
is absorbed by the molecular vibrations, causing a small portion to reemit at a
different frequency than the incident light. Light can be scatted either elastically
or inelastically. The former refers to Rayleigh scattering and is the most common
of the two. The latter is known as Raman scattering and involves the transfer
11
of energy between the molecule and photons. These molecules may return to a
higher or lower vibrational energy level. Hence, the Raman scattered light will
either have lost (Stokes shift) or gained (anti-Stokes shift) energy, in comparison
to the incident light [40]. Raman spectroscopy has the advantage of being able to
maintain sample integrity as the method only requires illumination of the sample
along with minimal sample preparation, and hence, is classed as a non-destructive
technique [44]. The technique can analyse matter in any state and has already been
shown possible to be used as a portable device [45]. Malka et al. [46] show a portable
technique that can provide Raman spectra of contaminated fingerprints (ammo-
nium nitrate, urea, urea nitrate, 2,4 and 3,4 DNT, potassium nitrate, TNT, RDX,
HMX and PETN) along with an image of the deposited fingerprint. The method
proved to be a highly sensitive technique, with a limit of detection being ~1 ng.
The primary challenge Raman spectroscopy faces is the high fluorescence back-
ground signal that can occur with certain incident light wavelengths [45].
Laser Induced Breakdown Spectroscopy
Laser induced breakdown spectroscopy (LIBS) is an atomic emission spectroscopy
technique, which can provide the composition of a molecule. Through high en-
ergy laser pulses applied to a sample, a plasma of ionised matter is formed. The
light emission from the plasma provide characteristic spectra, which can provide
the composition of the sample [47]. The advantages of LIBS are that no sample
preparation is required, it is sensitive, has fast analysis, can be used for any type
of matter and can be used as a stand-off technique in explosive material detection.
Stand-off techniques provide safety by allowing distance between those operating
the detection equipment and the sample [25]. In 2006, López-Moreno et al. [48] were
the first to demonstrate the use of a LIBS sensor for stand-off detection for a
variety of different explosive substances, including TNT, RDX and C4 in finger-
print deposits. The sensor could detect ~5 µg in a fingerprint deposit at a 30 m
range. However, a limitation of LIBS is its difficulty in discriminating between
explosive residues and materials of similar composition. There have been different
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approaches to address this problem, including De Lucia et al. [49] who employed
a double-pulse LIBS method that aims to reduce the influence that atmospheric
nitrogen and oxygen have on the signal; and Moros et al. [50] that present a math-
ematical algorithm. In 2011, Abdelhamid et al. [51] use optical catapulting-LIBS
(OC-LIBS) to detect TNT, DNT and MNT. OC-LIBS also provides a means to
discriminate between explosive and non-explosive residues; however, the method
requires access to the back of the sample. Lucena et al. [25] goes on to develop
a LIBS technique, which involves scanning and locating a surface (aluminium
or glass) that contains fingerprint deposits contaminated with different explosive
residues (DNT, TNT, chloratite, RDX and PETN). This method provided 100%
sensitivity for the recognition of explosive contaminated fingerprints at 31 m. It
was highlighted that environmental problems such as weathering affect the quality
of the print. LIBS offers many advantages but faces challenges in variability, due
to differences in energy of the laser with each pulse. The analysed sample area is
typically a few micrometres across and down, and so can be misrepresentative of
the bulk of the sample when in solid form.
Colorimetric Sensors
Colorimetric sensors are based on a colour change of a solution in the presence
of the molecule of interest. By measuring the absorbance of the solution, it is
possible to determine the concentration of the molecule of interest using the Beer-
Lambert law. Dorozhkin et al. [52] demonstrate a specific colorimetric test for field
detection of nitrogen dioxide based explosive compounds on different surfaces, in-
cluding fingerprints. The molecule (cymantree) which senses the nitrogen dioxide
turns a deep blue colour upon exposure to the nitrogen dioxide and UV irradia-
tion. More recently in 2015, Cross et al. [32] developed a colorimetric method that
involves the pre-treatment of a glass surface to detect urea nitrate. This test has
the advantage of using a molecule (9,10-diphenylanthracene) that enhances the
visualisation of the fingerprint. The test involves two different solutions that can
detect the urea nitrate by turning a yellow (p-dimethylaminobenzaldehyde) or
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red (p-dimethylaminocinnamaldehyde) colour when in contact with urea nitrate.
Thus, the method provides a quick and simple test for the detection of deposited
prints that are contaminated with urea nitrate. Although colorimetric sensors can
provide easy to use devices for non-specialised personnel as well as a cheap alter-
native to many other detection systems, colorimetric sensors can lack sensitivity
from interference from other molecules or the matrix [52].
The technique used in this research is a competitive immunoassay, which will be
described in detail below (Section 1.3). There have been no studies reported that
demonstrate the detection of explosive residue in fingerprints, using an immunoas-
say technique. However, Chapter 3 discusses the literature for the detection of
explosives with immunoassays, in general.
1.3 Immunoassays
Immunoassays are a type of analytical test that detect the presence or quantity
of a molecule of interest (analyte), with the use of antibodies. The test applies
a mechanism that is central to an animal’s immune system, based on a high
affinity interaction of an antibody and its substrate, an antigen. To appreciate this
technique, it is important to understand the two terms: ’antigen’ and ’antibody’
and their interaction.
1.3.1 Antigens
An antigen is a substance that is recognised as non-self or foreign in an animal. For
example, an antigen could be a protein present on a pathogenic microorganism.
The antigen generally contains a short sequence of amino acids which is responsi-
ble for antibody-antigen binding, called the epitope or antigenic determinant [53];
however, any chemical species can be an antigen. This accounts for the ability
of the immunoassay technique to detect a vast range of analytes [54]. Technically,
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antigens that evoke an immune response and consequently antibody production
are termed immunogens [55]. Hence, an immunogen is an antigen, but an antigen
is not necessarily an immunogen. In an immunoassay, the analyte replaces the
term antigen to refer to the substrate that the antibody is detecting and binding
to.
1.3.2 Antibodies
Antibody Classification
Antibodies are produced in the body to bind to the antigen that has elicited the
response, which is important for identifying and eradicating the foreign substance,
such as pathogens. Hence, this mechanism has to be a highly specific interaction
to prevent incorrect binding. Antibodies are large glycoprotein immunoglobulins
(Igs) [56]. There are different classes of Igs; for example, humans have five classes:
IgA, IgD, IgE, IgG and IgM. All classes are composed of heavy (~50 kDa) and
light (~25 kDa) polypeptide chains, along with variable and constant regions for a
given species. Each Ig class has a different biological function which is determined
by their heavy chains. This is a due to the constant regions being located at the
carboxyl termini of the heavy chains, and is the area responsible for binding to
effector targets [57].
For scientific research purposes, antibodies can either be monoclonal or polyclonal.
This is dependent on how they were raised, and consequently provides different
characteristics and advantages. Polyclonal antibodies are acquired by injecting the
antigen, i.e., the analyte (or analyte-carrier conjugate for small molecules), into
an animal. Blood is taken from the animal and once antibody concentrations are
at appropriate levels, purified antisera (sera containing antibodies) are obtained
from these collections [53]. This results in antibodies from different cell lineages
recognising the same antigen, by binding to different epitopes. Polyclonal anti-
bodies are cheap and relatively quick to produce, however they lack specificity and
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are not very reproducible. Monoclonal antibodies are produced from hybridoma
cells from the same cell lineage, resulting in identical clones. Hence, monoclonal
antibodies all recognise the same epitope on the analyte [58]. This means mono-
clonal antibodies share the same specificity and are reproducible, although they
are more expensive and take longer to produce compared to polyclonal antibodies.
Note that even though monoclonal antibodies have the same specificity, it does
not neccessarily mean that monoclonal antibodies have higher specificity. For
example, a monoclonal anti-TNT antibody may bind to toluene, dinitrotoluene
and trinitrotoluene (TNT) if the antibody recognises the toluene structure that
is common to all three molecules. Primary antibodies bind to the analyte; and
secondary antibodies bind to the primary antibody. The primary antibody that
is raised against a substance is termed ’anti-substance antibody’, with respect to
immunoassays it will be anti-analyte antibody, e.g., anti-TNT antibody.
Antibody Structure
The most commonly used antibody and Ig class in immunoassays is the IgG, pri-
marily due to its bioavailability in sera. The IgG is composed of four polypeptide
chains: two identical heavy polypeptide chains and two identical light polypeptide
chains. The chains are linked by disulphide bridges. The chains are formed from
repeating units of ~110 amino acids in length, which fold to form the globular
Ig domain. There are multiple Ig domains which make up the Ig structure, and
provide the characteristic Y-structure. This Ig domain consists of two layers of
beta-pleated sheets consisting of around five anti-parallel polypeptide chains that
are connected by a disulphide bridge. There are small loops which join the strands
that are next to each other, and it is these loops which consist of some of the most
highly variable sequences in the IgG structure. These loops are thus responsible
for antigen recognition [59]. The actual sequence of amino acids on the antibody
which binds the antigen is called the paratope. This is a complementary sequence
to the epitope on the antigen. The fragment antigen binding (Fab fragment) re-
gion encompasses all regions involving antigen recognition, i.e., the paratope and
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hypervariable loops. There are two Fab fragments on an IgG molecule, and they
are located at the amino termini of the heavy and light chains. Hence, one an-
tibody has the potential to bind to two antigens. At the carboxyl termini of the
heavy chains, or the ’tail’ of the antibody, lies the fragment crystallizable (Fc) re-
gion. The Fc region is constant between Igs of the same class within a species. As
stated previously, it is this region of the antibody which determines its biological
function [57]. Figure 1.3 summarises the structure of an IgG antibody.
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Figure 1.3: The structure of an antibody (IgG). Heavy chains are shown in green and
light chains are shown in blue. Constant regions are dark green (heavy chains) and dark
blue (light chains); whereas, variable regions are light green (heavy chains) and light blue
(light chains). Black lines represent disulphide bonds. Adapted from Janeway et al. [57]
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1.3.3 Antibody-Antigen Interaction
The primary antibody-antigen interaction is a rapid process that involves the
binding between the complementary epitope and paratope, providing specificity.
It is a high affinity interaction (105 to 1012 association constant) [58] requiring
extreme pH or salt concentrations to break it [56]. However, it involves fairly weak,
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non-covalent interactions, which suggests that the interaction occurs over a large
area of the Fab region. For multivalent antigens, secondary binding does occur,
i.e., multiple antibodies bound to one analyte, forming aggregations. However,
this does not apply to the small analyte (TNT) used in this research.
1.3.4 Immunoassay Classification
Methods vary between different immunoassays but all require an immobilised
component, labelled component and free analyte sample. There are numerous
ways immunoassays can be classified, though, most simply is to define them by
non-competitive or competitive. Non-competitive assays produce a signal which is
directly proportional to the amount of analyte in the sample; whereas, competitive
assays result in a signal that is inversely proportional to the amount of analyte
present in the sample [60]. The assays can be further categorised into homogenous
and heterogeneous. Immunoassays involve the binding between an antibody and
an analyte, and consequently there are often unbound elements. In order to ob-
tain a measurement from the immunoassay, the unbound analyte may need to be
separated from the bound analyte (heterogeneous) or can be measured without
separation (homogenous). Immunoassays are also classified by the type of label
used. The most common types of label used are fluorescent, enzyme, radioactive
and chemiluminescent [56].
The format used in this research is a competitive fluoroimmunoassay, i.e., de-
tection through the use of a fluorescent label. In this research, the anti-TNT
antibody is either unlabelled or labelled with the fluorescent dye: Alexa Fluor
488 (AF488). The anti-TNT antibody is primarily used in its labelled form; how-
ever, a labelled secondary antibody is required if the anti-TNT antibody is not
labelled. Note that the primary and secondary antibody are both labelled with
the same fluorescent dye (see Section 1.4). Competitive immunoassays are pri-
marily used in the detection of small molecular weight substances, such as TNT.
19
This is due to the method requiring the analyte to be bound by only one antibody;
as opposed to non-competitive immunoassays, which require multiple antibodies
binding to one analyte, i.e., sandwich immunoassays [61]. Multiple antibody bind-
ing is problematic for small molecules due to accessibility difficulties, and often
small analytes may be univalent (one epitope). In this research the competitive
immunoassay is performed on a plate and a lateral flow immunoassay (LFIA) for-
mat. The following components are required for both formats: an immobilised,
bound form of the analyte; a free form of the analyte; and an AF488 labelled
antibody (primary or secondary). The bound analyte is achieved by conjugating
the analyte to a large protein, which in this case is bovine serum albumin (BSA).
The competitive plate immunoassay for both labelled and unlabelled anti-TNT
antibody is illustrated in Figure 1.4. The bound form of the TNT (BSA-TNT) is
first immobilised on the solid surface material, i.e., the wells of a 384 well plate. A
sample, containing the free analyte (TNT) is added to the system, along with anti-
TNT antibody (primary antibody). The free TNT and the anti-TNT antibody
interact with one another, resulting in the anti-TNT antibody binding the TNT.
As the free TNT concentration is increased, the more anti-TNT antibody binding
sites are occupied by the free TNT. This reduces the amount of antibody available
to bind to the immobilised BSA-TNT. The system is washed, which means that
any anti-TNT that is not bound to the BSA-TNT will be removed. With labelled
anti-TNT antibody, the wells can then be immediately measured for fluorescence
intensity. If unlabelled anti-TNT antibody is used, a labelled secondary antibody
is added. The secondary antibody binds to any anti-TNT antibody that is bound
to the BSA-TNT, as any other anti-TNT antibody will have been removed from
the washing step. The more labelled antibody (primary or secondary) bound to
the BSA-TNT, the higher the fluorescence intensity. Therefore, as the free TNT
concentration increases, the less antibody available to bind to the BSA-TNT, and
the lower the fluorescence intensity. Hence, the fluorescence signal emitted is
inversely proportional to the amount of free TNT in the sample.
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Figure 1.4: Summary of the competitive plate assay with labelled (red arrows) and un-
labelled (blue arrows) anti-TNT antibody. The plate is washed three times with 100 µl
of 10 mM phosphate buffer with 80 mM NaCl and 0.22 mM Tween 20, pH 7.4 (PBST).
The plate is incubated at 37oC.
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The same competitive immunoassay principle involved in the plate immunoassay
was applied to the LFIA. In the LFIA format, BSA-TNT is deposited onto ni-
trocellulose instead of the wells of a plate. The deposited BSA-TNT is referred
to as the test line. A second line, called the control line, is deposited with horse
anti-mouse secondary antibody. This is unlabelled and is deposited further up
the strip from the test line. The control line binds anti-TNT antibody as a check
that the test has functioned properly, i.e., antibody has passed over the test and
control lines. The nitrocellulose with deposited lines is referred to as the test strip.
The anti-TNT antibody is deposited onto material that is termed the conjugate
pad. The sample pad is the material where the fingerprint, and consequently
the free TNT, are deposited. A solubilisation buffer is required, which solubilises
the analyte (TNT) and antibody (anti-TNT antibody) as it wicks through the
assembled test. The term ’wick’ is used to describe the movement of a solution by
capillary action. To ensure movement of the solution through the test, an adsor-
bent pad is assembled at the end of the test strip to draw the liquid through [62].
The preparation and assembly of the materials used in the LFIA are described in
Section 2.4. Once the components have been assembled, solubilisation buffer (see
Section 2.1) is added to the sample pad. The free TNT is solubilised as the solu-
tion moves through the sample pad. The solubilisation buffer, which contains the
solubilised TNT, then moves into the conjugate pad, which contains the AF488
labelled anti-TNT antibody. The solution solubilises the anti-TNT antibody. The
free TNT and anti-TNT antibody can then interact as they move along the test
strip, resulting in the antibody binding the TNT. The test and control lines are
at the end of the test strip, just before the adsorbant pad. As in the plate assay,
the anti-TNT antibody can not bind to the BSA-TNT (test line) when bound to
the free TNT. Therefore, the higher the concentration of free TNT in the sample,
the lower the concentration of labelled anti-TNT antibody available to bind to
the test line, and the lower the fluorescent signal. Thus the plate assay and LFIA
have exactly the same response to free TNT in the sample, which is that the
fluorescence signal is inversely proportional to the concentration of free TNT in
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the sample.
1.4 Fluorescence
As stated above, in this research the technique employed is a competitive fluo-
roimmunoassy, where the antibody is labelled with a fluorescent dye (AF488).
The fluorescence signal is measured, which provides a relative intensity that is
indirectly proportional to the the amount of TNT in the sample. Fluorescence is
described as the emission of photons "associated with electrons moving from an ex-
cited state to a ground state" [40]. Molecules which exhibit fluorescence are called
fluorophores. At room temperature electrons typically exist in only the lowest
electronic energy level, referred to as the molecular ground state. A molecule can
be excited, i.e., promoted to an electronic state of higher energy, by absorption
of the energy of a photon [63]. A large amount of energy is required for an electron
to undergo an electronic transition, typically requiring the energy from UV or
visible light. The molecular electronic transitions are governed by selection rules
outlined by a set of quantum mechanical equations. The selection rules result in
’allowed’ electronic transitions; although forbidden transitions do occur, but with
much lower probability [40]. Fluorescence involves allowed transitions between sin-
glet electronic states. Singlet electronic states refers to two electrons which have
opposite spin orientation, or ’paired’ electrons [63]. Therefore, in an excited singlet
electronic state, the excited electron remains paired (opposing spin) to an electron
in the ground state [64].
A Jablonski diagram is shown in Figure 1.5 and is often used to illustrate the
fluorescence process. As seen in stage (1), an electron in the ground singlet state,
denoted S0, absorbs energy from a photon of incident radiation at a given wave-
length. This results in an electron being promoted to the first (S1) or higher
energy excited singlet state (Sn) (as seen in stage (2)). The molecule can be ex-
cited to higher vibrational levels within an excited electronic state [40]. Following
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Kasha’s rule, an electron in Sn (n>1) rapidly (10-22 s) undergoes non-radiative
relaxation to the lowest excited electronic state (S1) [64]. Vibrational relaxation
(stage (3)) involves the electron dissipating to a lower vibrational energy level
through the release of kinetic energy. Internal conversion is non-radiative change
in state (conserves energy), for example from S2 to a higher vibrational level of S1,
followed by vibrational relaxation. Once the electron is in the lowest vibrational
energy level of the lowest excited electronic energy level (S1), the electron can
then drop down to S0 by releasing energy through the emission of a photon (stage
(5)), or decay non-radiatively. As energy must be conserved, the energy of the
photon emitted is of lower energy (longer wavelength) than the photon absorbed,
as some energy is released through processes such as vibrational relaxation in the
excited states. This is known as the Stokes shift [64]. The wavelengths emitted
from a molecule during fluorescence are defined in the emission spectrum. The
wavelengths absorbed by a molecule are referred as the excitation spectrum.
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Figure 1.5: A Jablonski’s diagram to illustrate the fluorescence process. Electronic
energy levels are shown as solid, black, horizontal lines; vibrational energy levels are
shown as solid, grey, horizonal lines. Absorbance is shown as solid, blue, vertical arrows;
fluorescence is shown as solid, green, vertical arrows. Vibrational relaxtion is shown as
solid, black curved arrows; internal conversion is shown as solid, red, curved arrows.
Excitation light is shown as blue, dashed, curved arrows; emitted light is shown as green,
dashed, curved arrows. Adapted from Lakowicz [64].
In this research, the anti-TNT antibody is labelled with the fluorescent dye: Alexa
Fluor R© 488 (AF488) tetrafluorophenyl (TFP) ester. The advantage of using a flu-
orescent label is that it provides high sensitivity. This is a result of fluorescence
having no background interference from other molecules, i.e., TNT. The AF488
TFP ester reacts with the -amino group on lysine residues of the anti-TNT anti-
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body, shown in Figure 1.6. The reaction is determined by the concentration and
reactivity of the reagents. The class and basicity of an amino acid can affect its
reactivity. The lysine residues are both aliphatic and relatively basic, which makes
them reactive with the AF488 TFP ester. Hence, this reaction is also pH depen-
dent as there are fewer free base aliphatic amines at pH values below eight [65].
The absorption and emission spectra of the AF488 dye is shown in Figure 1.7.
Figure 1.6: A scheme showing the reaction between the AF488 TFP ester and lysine.
Adapted from Johnson and Spence [65].
Figure 1.7: Absorbance (blue, dotted line) and emission (red, solid line) spectra of the
AF488 dye [66].
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1.5 Thesis Outline
The main two aims of this research are firstly to demonstrate that TNT can be
detected with a competitive fluoroimmunoassay technique. The second aim is to
develop the technique into a lateral flow immunoassay test, for the detection of
TNT in fingerprints. The different materials and methods used throughout this
research will be described in Chapter 2.
The research in Chapter 3 investigates the first aim, which is to demonstrate
that TNT can be detected using a competitive immunoassay format. This re-
search utilises a 384 well plate to immobilise the relevant immunoassay chemistry
onto the surface of the wells (plate immunoassay). The chapter begins by out-
lining the importance of TNT detection, followed by an explanation of the plate
immunoassay technique used in the research, the relative advantages of the plate
immunoassay and current literature that detects TNT with immunoassays. Chap-
ter 3 then discusses the research performed, beginning with studies that focus on
the binding specificity of the unlabelled anti-TNT to the bound form of TNT,
i.e., BSA-TNT conjugate and the free form of TNT. Next, the labelling of the
anti-TNT antibody with the fluorescent dye (AF488) was optimised, finding the
optimal number of moles of labelled dye to mole of anti-TNT antibody. To find
the maximum sensitivity of the assay, the composition of the solubilisation buffer
and the concentrations of the BSA-TNT and anti-TNT antibody were optimised.
Finally, the effect of the presence of a fingerprint was tested in the optimised
competitive plate immunoassay. The chapter then provides a section on the con-
clusions reached from the findings of the research described in Chapter 3.
In Chapter 4, the research focuses on the second aim of the research, which is
to develop a competitive LFIA test for the detection of TNT in fingerprints. The
chapter begins with an introduction to the advantages and uses of a LFIA tech-
nique for the detection of TNT in fingerprints. This is followed by a description
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of the LFIA technique used in the research described in Chapter 4, the relative
advantages of the LFIA over the plate immunoassay, and current literature that
employs LFIA mechanism for explosive detection. The chapter then discusses the
results from the direct wick and LFIA studies. The first studies focus on using the
direct wick technique. This is due to the direct wick having a more simple design
than the LFIA, reducing interference from the different materials in the LFIA.
Firstly, the optimised plate immunoassay conditions are applied to the direct wick
format. From these results it was clear that the direct wick conditions required
further optimisation. Therefore, the nitrocellulose was treated with different solu-
tions to block non-specific binding of the anti-TNT antibody and/or TNT, and to
enhance wicking of the solution through the strip. Different TNT concentrations
were then tested to find the sensitivity of the assay. At this point, there was no
competition observed. Therefore, the plate immunoassay was tested using direct
wick conditions, alongside a direct wick experiment. This was to test that the
competitive immunoassay developed in Chapter 3 could function under the same
temperature and time constraints as in the direct wick method. Different BSA-
TNT concentrations are then tested to improve the sensitivity of the direct wick
assay. Once, the optimal BSA-TNT concentration was selected this concentration
was carried forward to be tested with a range of TNT concentrations. The con-
ditions were then applied to the LFIA. The chapter then concludes the findings
from the research conducted within Chapter 4.
Chapter 5 discusses the conclusions from the research carried out in Chapters
3 and 4. Chapter 5 then outlines some possibilities for future work based on the
conclusions of this research.
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Chapter 2
Experimental
This chapter provides the different materials and methods used in this research.
The methods used within this research are adapted from protocols designed by
Intelligent Fingerprinting.
2.1 Buffers
In this research, there are various experiments which test different buffer compo-
sitions to optimise conditions of a given assay. The following chemicals that made
up the different solutions were obtained from Sigma Aldrich: sodium chloride
(NaCl), Tween 20, Tween 80, polyvinylpyrrolidone (PVP) and methanol. The
bovine serum albumin (BSA) was obtained from Fitzgerald Industries Interna-
tional. The composition of the main buffers used in this research are summarised
in Table 2.1. Any variations of the buffers will be stated within the relevant text.
For example, in Section 4.1, the nitrocellulose blocking buffer has different com-
positions tested during optimisation. However, the final, optimised nitrocellulose
blocking condition is stated below in Table 2.1.
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Table 2.1: Summary of the buffer compositions used in this research.
Abbreviation Composition pH
SBB 100 mM Sodium Bicarbonate Buffer 8.02 or 9.5
PBS 10 mM Phosphate Buffer, 150 mM NaCl 7.4
PBST 10 mM Phosphate Buffer, 80 mM NaCl,
0.22 mM Tween 20
7.4
Solubilisation
Buffer
10 mM Phosphate Buffer, 40 mM NaCl,
0.12 mM Tween 20
7.4
Nitrocellulose
Blocking Buffer
10 mM Phosphate Buffer, 3% PVP 7.4
2.2 Plate Assays
2.2.1 Direct Binding Plate Assay
The bovine serum albumin-analyte conjugate (BSA-TNT, received as a gift from
DSTL) was prepared by diluting to a desired concentration (variable in experi-
ments) in 100 mM sodium bicarbonate buffer, pH 8.02 (SBB). The wells of the
Nunc R© MaxiSorpTM 384 well plates (Fisher Scientific) were coated with the BSA-
TNT and incubated for 2 hours in the LTE Incubator IP60 UF 60L (Scientific
Laboratory Supplies Ltd) at 37oC. Wells were washed 3 times with 100 µl of PBST
(10 mM phosphate buffer, 80 mM NaCl, 0.22 mM Tween 20, pH 7.4). Either 10 µl
of the labelled (with Alexa Fluor R© 488) or unlabelled primary mouse monoclonal
anti-TNT antibody (DSTL), which was diluted in PBS (10 mM phosphate buffer,
150 mM NaCl, pH 7.4), was added to the wells. The plate was incubated for a
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further 1 hour at 37oC and washed 3 times with 100 µl of PBST. For plate assays
which used unlabelled primary anti-TNT antibodies, the Alexa Fluor R© 488 goat
anti-mouse IgG (H+L) secondary antibody (Life Technologies) was added to the
wells and incubated for 1 hour at 37oC. The plate was then washed with 100
µl of PBST, 3 times. To the washed wells, 50 µl of PBST was added and then
analysed using a BMG LABTECH CLARIOstar R© High Performance Multimode
Microplate Reader, at excitation and emission wavelengths of 485 nm and 530
nm, respectively. The results were analysed in Microsoft Excel and normalised to
the fluorescence reading at 100 µg ml-1 of anti-TNT antibody.
2.2.2 Competitive Plate Assay
The competitive plate assay follows the same layout as the direct binding plate as-
say. The BSA-TNT was prepared by diluting to a desired concentration (variable
in experiments) in 100 mM sodium bicarbonate buffer pH 8.02 (SBB). The wells
of the Nunc R© MaxiSorpTM 384 well plates (Fisher Scientific) were coated with 10
µl of the BSA-TNT (variable concentration between experiments) and incubated
for 2 hours in the LTE Incubator IP60 UF 60L (Scientific Laboratory Supplies
Ltd) at 37oC. Wells were washed 3 times with 100 µl of PBST (10 mM phosphate
buffer, 80 mM NaCl, 0.22 mM Tween 20, pH 7.4). The TNT reference solution
(Thames Restek) was added to the wells. Note that the TNT reference solution
was diluted in a range of buffers, stated within the relevant text. This was fol-
lowed by the addition of either the labelled (with Alexa Fluor R© 488) or unlabelled
anti-TNT antibody (DSTL), which was diluted in PBS (10 mM phosphate buffer,
150 mM NaCl, pH 7.4). The plate was incubated for a further 1 hour at 37oC
and washed 3 times with 100 of µl PBST. For plate assays which used unlabelled
primary anti-TNT antibodies, the Alexa Fluor R© 488 goat anti-mouse IgG (H+L)
secondary antibody (Life Technologies) was added to the wells and incubated for
1 hour at 37oC. The plate was then washed with 100 µl of PBST, 3 times. To
the washed wells, 50 µl of PBST was added and then analysed using a BMG
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LABTECH CLARIOstar R© High Performance Multimode Microplate Reader, at
excitation and emission wavelengths of 485 nm and 530 nm, respectively. The
results were analysed in Microsoft Excel and normalised the highest fluorescence
reading at 0 µg ml-1 of TNT. The average was taken of the normalised values for
each condition and displayed in the relevant figures in Chapter 3.
2.2.3 Quenching Studies
Starting with the same format as the competitive plate assay, the BSA-TNT was
prepared by diluting to 1 µg ml-1 in SBB (100 mM sodium bicarbonate buffer,
pH 8.02). The wells of the Nunc R© MaxiSorpTM 384 well plates (Fisher Scientific)
were coated with the BSA-TNT and incubated for 2 hours in the LTE Incubator
IP60 UF 60L (Scientific Laboratory Supplies Ltd). Wells were washed 3 times
with 100 µl of PBST (10 mM phosphate buffer, 80 mM NaCl, 0.22 mM Tween
20, pH 7.4). Labelled anti-TNT antibody was diluted to 25 µg ml-1 in PBS (10
mM phosphate buffer, 150 mM NaCl, pH 7.4) and added to the coated wells. The
plate was incubated for 1 hour at 37oC before the wells were washed with 100 µl of
PBST, 3 times. To the wells, 10 µl of the TNT reference solution was added and
the plate was immediately read in a BMG LABTECH CLARIOstar R© High Per-
formance Multimode Microplate Reader, at excitation and emission wavelengths
of 485 nm and 530 nm, respectively. Results were analysed in Microsoft Excel and
normalised to the fluorescence reading at 0 µg ml-1 TNT. The average was taken
of the normalised values for each condition and displayed in the relevant figures
in Chapter 3.
2.2.4 Competitive Plate Assay with TNT Spiked Finger-
prints
This method differs from the competitive plate assay outlined above in Section
2.2.2, as the TNT reference solutions include the addition of fingerprint deposits.
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Fingerprint Deposition
First of all, two sets of fingerprints were deposited onto glass microscope slides
(Fisher Scientific). Each glass slide had a single finger or thumb pressed onto the
centre of the glass slide. The presence of the fingerprint deposit can be seen by
eye. Therefore, after each fingerprint deposition, the slide was checked to ensure
successful fingerprint deposition.
Fingerprint Extraction
A 20 µl drop of solubilisation buffer (10 mM phosphate buffer, 40 mM NaCl, 0.12
mM Tween 20, pH 7.4) was pipetted onto the fingerprint and a cover slip (Fisher
Scientific) was placed on top of the drop of solubilisation buffer and fingerprint
for 2 mins. The cover slip was then lifted, to ~45o angle, maintaining contact
between the glass slide and one edge of the cover slip. The cover slip was then
rubbed over the fingerprint 10 times to encourage extraction of the fingerprint
from the slide. The liquid that contains the solubilisation buffer and fingerprint
is then pipetted into a 1.5 ml tube.
TNT Spiked Fingerprints
There are two sets of fingerprints in this technique: the first set is spiked with
TNT before fingerprint extraction, and the second set is spiked with TNT after
fingerprint extraction. Spiking refers to a known concentration of TNT being
added to the fingerprint deposit. A series of TNT reference solutions were pre-
pared in solubilisation buffer (10 mM phosphate buffer, 40 mM NaCl, 0.12 mM
Tween 20, pH 7.4). To the first set of deposited fingerprints, 10 µl of the TNT
reference solution was added on top of the deposited fingerprints, i.e. the finger-
print deposits were ’spiked’ with TNT. The glass slides were placed in the LTE
Incubator IP60 UF 60L (Scientific Laboratory Supplies Ltd) at 37oC, for 1 hour.
The slides were removed from the incubator. The spiked fingerprints were then
extracted as detailed above (Section 2.2.4).
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The second set of fingerprints were deposited on the glass slides and immedi-
ately incubated for 1 hour at 37oC, in the LTE Incubator IP60 UF 60L (Scientific
Laboratory Supplies Ltd). The slides were removed from the incubator and ex-
tracted, as described above (Section 2.2.4). The TNT reference solutions were
then added to the extracted fingerprint solutions. Hence, the fingerprints were
spiked with TNT after extraction.
Note that a control set of TNT reference solutions were prepared without any
fingerprint addition. The different TNT-containing solutions (with and without
extracted fingerprints) could then be used in the competitive plate assay format.
Testing of the TNT Spiked Fingerprints
The TNT spiked fingerprints were tested in the competitive plate assay format.
As described before, wells of the Nunc R© MaxiSorpTM 384 well plates (Fisher Scien-
tific) were coated with 10 µl of 1 µg ml-1 of BSA-TNT (diluted in 100 mM sodium
bicarbonate buffer, pH 8.02) and incubated for 2 hours in the LTE Incubator IP60
UF 60L (Scientific Laboratory Supplies Ltd) at 37oC. Wells were washed 3 times
with 100 µl of PBST (10 mM phosphate buffer, 80 mM NaCl, 0.22 mM Tween 20,
pH 7.4). The various TNT reference solutions, which included: fingerprints spiked
with TNT before extraction; fingerprints spiked with TNT after extraction; and
TNT reference solutions without any fingerprint addition, were added to the wells
(10 µl ). This was followed by the addition of 10 µl of 6.25 µg ml-1 labelled anti-
TNT antibody solution (DSTL), which was diluted in PBS (10 mM phosphate
buffer, 150 mM NaCl, pH 7.4). The plate was incubated for a further 1 hour at
37oC and washed 3 times with 100 µl of PBST. To the washed wells, 50 µl of PBST
was added and then analysed using a BMG LABTECH CLARIOstar R© High Per-
formance Multimode Microplate Reader, at excitation and emission wavelengths
of 485 nm and 530 nm, respectively. The results were analysed in Microsoft Excel
and normalised to the fluorescence reading at 0 µg ml-1. The average was taken
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of the normalised values for each condition and displayed in the relevant figures
in Chapter 3. The half maximal inhibitory concentration (IC50) of the solutions,
with and without fingerprints, were calculated using SigmaPlot.
2.3 Antibody Labelling
The anti-TNT antibody labelling method is based on the ’Invitrogen Alexa Fluor R©
488 Protein Labeling Kit’ manual [67]. The labelled antibody purification method
is based on the instructions provided with the PD-10 columns (GE Healthcare
Life Sciences) [68]. Corning R© Spin-X R© UF 10K concentrators (Sigma Aldrich)
were equilibrated prior to use with 500 µl of SBB (100 mM sodium bicarbonate
buffer, either pH 8.02 or 9.5) and spun for 12 mins at 5,000 g on the MSE Mi-
cro Centaur Pulse centrifuge. The anti-TNT antibody (DSTL) was concentrated
by adding 500 µl of antibody to equilibrated concentrator tubes and spun for 18
mins at 10,000 g. The concentration of the antibody was determined before and
after concentration by placing the solutions in the UV-Vis Hitachi U-3000 Spec-
trophotometer and recording the absorbance at 280 nm, using the UV Solutions
software. The concentration was then calculated using Equation 2.2 (see Section
2.5). The antibody concentrate was resuspended in SBB to make a final concen-
tration of 2 mg ml-1. The dye, Alexa Fluor R© 488 TFP ester (Life Technologies),
was solubilised in dimethyl sulfoxide (DMSO). Note that the concentration of the
Alexa Fluor R© 488 TFP ester varied between 0.5 mg ml-1 and 10 mg ml-1, and
will be noted in the relevant text. The variable concentration of dye added pro-
vided different numbers of dye molecules labelled to the anti-TNT antibody. The
concentrated antibody solution was added to the dye, mixed thoroughly and then
incubated at room temperature in the dark, for 1 hour. The antibody-dye solution
was then purified with PD-10 columns (GE Healthcare Life Sciences). The PD-10
columns were firstly equilibrated with 10 ml of SBB. Once all the solution had
run through the column, 450 µl of the antibody-dye solution was added. After
the antibody dye solution had moved into the column, a further 2 ml of SBB was
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added. After ~2 mins, a colour gradient could be observed as the antibody dye
solution began to separate into: labelled antibody; flow through between labelled
antibody and unbound dye (flow between); and unbound dye (see Figure 2.1).
A further 4 ml of SBB was added and then the various fractions (labelled anti-
body, flow between, unbound dye) were collected in 1.5 ml tubes. The collected
fractions were separately ran on the UV-Vis Hitachi U-3000 Spectrophotometer.
The absorbances at 280 nm and 494 nm were recorded, using the UV Solutions
software, for analysis of the composition of the solutions (see Section 2.5).
Labelled	  Antibody	  
Flow	  Between	  
Unbound	  Dye	  
Collection	  Tube	  1	   Collection	  Tube	  2	   Collection	  Tube	  3	  
Puri<ication	  Column	  
Figure 2.1: A schematic diagram demonstrating the collection of the different fractions
of the antibody-dye solution during purification. The labelled antibody was collected in
Tube 1; the flow between labelled anti-TNT antibody and unbound dye (referred to as
’flow between’) was collected in Tube 2; and the unbound dye was collected in Tube 3.
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2.4 Lateral Flow Immunoassay
2.4.1 Material Preparation
Test Strips
A BioDot XYZ3060 Dispense Platform was primed with 10 cycles of ethanol
(Sigma Aldrich), followed by 10 cycles of 0.05% BioTerge AS-40, 10 cycles of the
SBB (100 mM sodium bicarbonate buffer, pH 8.02) and 3 cycles of either horse
anti-mouse IgG antibody (Vector Laboratories Ltd) or BSA-TNT (DSTL) for the
control and test line, respectively. Nitrocellulose (Immunopore RP, GE Healthcare
Life Sciences) was cut into 25 mm by 300 mm strips. The control (horse anti-
mouse antibody) and test (BSA-TNT) lines were deposited onto the nitrocellulose
at a deposition rate of 800 nl cm-1 using the primed BioDot XYZ3060 Dispense
Platform. Note that the control line was dispensed from line 1 and the test line
was dispensed from line 3, providing a 3 mm distance between the deposited
lines. The nitrocellulose was placed on top of a sheet of lint-free tissue inside a
plastic box that contained silica gel (Sigma Aldrich). The nitrocellulose was left
to dry overnight in the closed box, at room temperature. The tissue and silica gel
were removed from the box and 75 ml of the nitrocellulose blocking solution (10
mM phosphate buffer, 3% PVP, pH 7.4) was poured over a strip of nitrocellulose
and ’rocked’ on a Stuart Scientific Mini-Orbital Shaker S05, for 20 mins. The
nitrocellulose was removed from the solution and placed on a fresh sheet of lint-
free tissue inside a new plastic box that contained silica gel. The box was placed
in the LTE Incubator IP60 UF 60L (Scientific Laboratory Supplies Ltd) to dry
the nitrocellulose at 37oC, overnight. The nitrocellulose was then cut into 4 mm
by 25 mm test strips using a guillotine (BioDot CM4000 Guillotine Cutter).
Conjugate Pads
Either Fusion 5 (GE Healthcare Life Sciences) or Grade 8964 (Ahlstrom) were
used as the conjugate pad material. The conjugate pad material was cut with
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a guillotine (BioDot CM4000 Guillotine Cutter) into 4 mm by 10 mm sections.
Labelled anti-TNT antibody was prepared in PBS (10 mM phosphate buffer,
150 mM NaCl, pH 7.4) to a concentration of 6.25 µg ml-1. The conjugate pads
were stood vertically in the wells of a Nunc R© MaxiSorpTM 384 well plate (Fisher
Scientific). Using a pipette, 10 µl of the labelled anti-TNT antibody solution was
deposited on the top of each conjugate pad, moving from left to right as the
solution was added. The ’loaded’ conjugate pads were left to dry overnight at
37oC in a LTE Incubator IP60 UF 60L (Scientific Laboratory Supplies Ltd).
Sample Pads
Either Fusion 5 (GE Healthcare Life Sciences) or Ahlstrom Grade 8964 was used
for the sample pad material. The sample pads were backed (by Adhesive Re-
search). TNT reference solutions were prepared in solubilisation buffer (10 mM
phosphate buffer, 40 mM NaCl, 0.12 mM Tween 20, pH 7.4). The sample pads
were spiked with 10 µl of TNT standard solution, by adding the solution to the
centre of the sample pad. The sample pads were dried for 1 hour at 37oC in a
LTE Incubator IP60 UF 60L (Scientific Laboratory Supplies Ltd).
Wick
In the direct wick experiments, the material used for the wick was Ahlstrom
Grade 319 that was cut into 8 mm by 8 mm sections, using the guillotine (BioDot
CM4000 Guillotine Cutter). In the lateral flow immunoassay, the material used
for the wick was Ahlstrom Grade 320 that was cut into 3 mm by 22 mm sections
with the guillotine.
2.4.2 Direct Wick Assembly and Testing
Nitrocellulose test strips were prepared as described in Section 2.4.1. The test
strips were then cut to a point at the bottom of the strip i.e. at the opposite end
to where the test and control lines were deposited. A wick (see Section 2.4.1) was
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placed at the top of a test strip and clipped in place (see Figure 2.2). Labelled anti-
TNT antibody solution was prepared in PBS (10 mM phosphate buffer, 150 mM
NaCl, pH7.4) to a concentration of 6.25 µg ml-1. The TNT reference solutions
were prepared in solubilisation buffer (10 mM phosphate buffer, 40 mM NaCl,
0.12 mM Tween 20, pH 7.4). The antibody and TNT solutions were added to
a separate vial, in equal volumes to form the ’premixed solutions’. A 20 µl drop
of the premixed solution was positioned at the centre of the base of a 2 ml self-
standing microcentrifuge tube (Simport R©). The 2 ml tube was then laid along its
side. The bottom, pointed end of the assembled strip was then placed into the drop
so that the solution could wick through the strip. Once all the solution had been
absorbed through the test strip, a further 20 µl of solubilisation buffer was added at
the base of the 2 ml self-standing tube. After all the solubilisation buffer had been
absorbed, the wick was removed and the test strip was placed in the ESEQuant
Lateral Flow Reader (Qiagen), where the fluorescence was measured at excitation
and emission wavelengths of 470 nm and 520 nm, respectively. Immediately after,
the test strip was fluorescently imaged using an Optical Breadboard Imaging
Device designed by EG Technology (see Figure 2.3), with an exposure of 1 sec.
The results were processed in Microsoft Excel.
39
2 ml Tube
Premixed antibody/
analyte solution or 
solubilisation buffer
Clip
Direction of Flow
(a)
(b)
(c)
Adsorbent Pad
Test Strip Deposited Test and Control Lines
Figure 2.2: A schematic diagram summarising the direct wick experiment. A) shows the
different components required; B) shows the assembled components that are clipped into
place; C) shows the experiment at set up. Note that 20 µl of premixed antibody/analyte
solution is allowed to wick through the test strip first before a further 20 µl of solubili-
sation buffer (10 mM phosphate buffer, 40 mM NaCl, 0.12 mM Tween 20, pH 7.4) is
added.
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Figure 2.3: The Optical Breadboard Imaging Device designed by EG Technology that
was used to take images of the nitrocellulose test strips.
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2.4.3 Lateral Flow Immunoassay Assembly and Testing
The prepared components, outlined in Section 2.4.1, were assembled together
as shown in Figure 2.4. Note that the components were backed (by Adhesive
Research) to provide support and ease of handling during assembly and testing. To
a reagent resevoir (Sigma Aldrich), 1 ml of solubilisation buffer (10 mM phosphate
buffer, 40 mM NaCl, 0.12 mM Tween 20, pH 7.4) was added. The exposed
bottom edge of the sample pad was immersed into the solubilisation buffer, so
that the cassette was aligned vertically. The solution was allowed to wick through
the system for 8 mins. The cassette was then placed in the ESEQuant Lateral
Flow Reader (Qiagen), where the fluorescence of the test and control line was
measured. The excitation and emission wavelengths were 470 nm and 520 nm,
respectively. The test strips were then fluorescently imaged using an Optical
Breadboard Imaging Device (designed by EG Technology), with an exposure of 1
second. Results were analysed in Microsoft Excel.
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Cassette
(b)
(c)
Backed sample pad
Conjugate pad
Adsorbent pad
Test strip
(a)
Deposited test line Deposited control line
Direction of Flow
Figure 2.4: Summary of the assembly of the lateral flow components. A) shows the
labelled individual components, before assembly; B)shows the assembled components;
and C) shows the assembled components within the cassette. Note that the components
are not to scale.
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2.5 Equations
The following equation was used to determine the limit of detection, where rele-
vant:
Limitofdetection = 3 ∗
[
SBlank
n
]
(2.1)
The following equations were used to determine antibody concentration before
antibody labelling:
[Antibody],M =
[
A280
(Antibody × l)
]
×DF (2.2)
A280 = absorbance at 280 nm, variable
Antibody = extinction coefficient of antibody, 208,000 L mol-1 cm-1 [67]
l = path length, 1 cm
DF = dilution factor, variable
[Antibody], g L−1 = [Antibody],M ×MWAntibody (2.3)
[Antibody], M = antibody concentration from Equation 2.2, variable
MWAntibody = molecular weight of antibody, 150,000 g mol-1 [67]
The following equations were used to determine antibody concentration after an-
tibody labelling:
[Labelled Antibody],M =
[
(A280 − (A494 × CF ))
(× l)
]
×DF (2.4)
A280 = absorbance at 280 nm, variable
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A494 = absorbance at 494 nm, variable
Antibody = extinction coefficient of antibody, 208,000 L mol-1 cm-1 [67]
l = path length, 1 cm
CF = correction factor of dye absorbing at 280 nm, 0.11 [67]
DF = dilution factor, variable
[LabelledAntibody], g L−1 = [LabelledAntibody],M ×MWAntibody (2.5)
[Labelled Antibody], M = antibody concentration from Equation 2.4, variable
MWAntibody = molecular weight of antibody, 150,000 g mol-1 [67]
The following equation was used to determine the molar dye to protein ratio:
Molar ratio of dye : antibody =
[
A494
([LabelledAntibody],M × Dye × l)
]
(2.6)
A494 = absorbance at 494 nm, variable
Dye = extinction coefficient of dye, 71,000 L mol-1 cm-1 [67]
l = path length, 1 cm
[Labelled Antibody], M = antibody concentration from Equation 2.4, variable
DF = dilution factor, variable
Equations were obtained from the Alexa Fluor R© 488 antibody labelling kit (Life
Technologies) manual [67].
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Chapter 3
Detection of TNT using a
Competitive Immunoassay
Immobilised on a 384 Well Plate
TNT is one of the most commonly used high explosives [69] due to its low sen-
sitivity to detonation by shocks and friction [70]. TNT is an explosive material
utilised in criminal activity, and has demanded quick, sensitive and reliable de-
tection methods to prevent catastrophic events from occuring [71]. Immunoassays
use antibodies that are specific to the analyte (TNT, in this instance) to detect
the presence of the analyte in a sample. The antibody-analyte binding is a high
affinity and highly specific interaction, providing a sensitive assay without sample
preparation. With reference to TNT, the TNT molecule has a low molecular mass
of 227.13 g mol-1. As described in Chapter 1, this results in the competitive for-
mat being the choice of immunoassay for the detection of TNT, as it only requires
the binding of one antibody to the TNT. A non-competitive format requires the
binding of two antibodies to the analyte, which is often physically not possible to
low molecular mass analytes.
The primary aim of the research described in this chapter is to demonstrate that
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TNT can be detected in a competitive immunoassay format. All immunoassays
were performed using a 384 well plate, and are subsequently referred to as ’plate
immunoassays’. The presence of TNT was detected by measuring the fluorescence
signal using a CLARIOstar Plate Reader. Note, in the competitive immunoas-
say format the TNT concentration is indirectly proportional to the fluorescence
intensity. Firstly, the specificity of the anti-TNT antibody was tested, demon-
strating the ability of the antibody to specifically recognise both the free form
of the TNT and the bound form (BSA-TNT conjugate) of TNT. Next, the num-
ber of moles of labelled fluorescent dye (AF488) per mole of anti-TNT antibody
was optimised. The binding specificity of the antibody was also assessed after
labelling, as labelling can disrupt the structure, and consequently, the specificity
of the antibody. Any quenching effects on the fluorescence signal emitted by the
AF488 dye bound to the anti-TNT antibody by TNT were examined, again in
a plate assay. The buffer that was used to solubilise the TNT, named the ’solu-
bilisation buffer’, was then optimised to contain the concentrations of the buffer
components for optimal sensitivity in the competitive plate assay. The anti-TNT
antibody and the BSA-TNT conjugate (BSA-TNT) concentrations were also op-
timised in the plate assay. Finally, as the end goal of the research was to produce
a competitive immunoassay based test to detect TNT in fingerprint deposits, the
effect of fingerprint addition in the system was tested to ensure the sensitivity of
the assay was not affected by the fingerprint presence, i.e., by non-specific binding
between the antibody to the components in the fingerprints.
This chapter will firstly discuss the importance of the detection of TNT, followed
by the advantages of using the competitive immunoassay immobilised on a 384
well plate for initial TNT detection studies. The advantages of using fingerprints
and plate immunoassay techniques that have been published in the literature have
also been discussed. Finally, the research results are discussed and then some con-
clusions drawn from the research presented in this chapter.
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3.1 Introduction
TNT is the most commonly used explosive [72], due to its relative high stability and
low sensitivity to detonation. The low melting point allows TNT to be melted,
which makes it easily poured into ammunition without risk of explosion. The sta-
bility of TNT is also appealing to criminal organisations, as it is safer to handle
compared to other high explosives. The use of explosive materials in criminal
activity [73], such as terrorism, has created a demand for sensitive, reliable and
quick detection tests to be used for security measures in environments such as
airports. It is critical to be able to detect TNT or to identify people or items that
have been in contact with TNT, in the hope of preventing catastrophic, criminal
events from occurring. TNT and its metabolites are also toxic to a wide range
of organisms, from humans to aquatic life [23]. Therefore, TNT not only poses a
threat to life from the primary destructive effects from the explosion but also from
long term effects by contaminating the surrounding environment. In situations
where people may be exposed to TNT, a technique to be able to detect TNT
would be necessary to ensure those exposed are not in contact with dangerous
levels of TNT. For example, monitoring workers in ammunition factories.
The fluoroimmunoassay used in the research described in this chapter was im-
mobilised on a 384 well plate, referred to as a plate immunoassay. As described
in Chapter 1, a bound form of TNT (BSA-TNT) was immobilised onto the wells
of the plate. Anti-TNT antibody and a sample containing TNT are added to
the wells. There was competitive binding of the anti-TNT antibody between the
bound form and free form of TNT. As the TNT in the sample was increased,
less anti-TNT antibody was available for binding to the BSA-TNT. Either the
anti-TNT antibody was labelled, or a labelled secondary anti-TNT antibody was
required. Higher concentrations of TNT in the sample, result in lower amount
of labelled antibody bound to the BSA-TNT, and a lower fluorescent intensity
was measured in the plate reader. The fluorescent dye used in this research was
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the Alexa Fluor R© 488, selected for its high photostability, pH stability over the
range of 4 to 10 and its high fluorescent yield. Generally, lower background signals
are observed when using a fluorescent dye, which improves sensitivity of the assay.
The plate immunoassay offers many advantages for initial studies. Firstly, the
high number of wells (384) in the plate allows for a large amount of samples
and conditions to be tested simultaneously, ideal for optimisation studies. The
antibody-analyte interaction in the plate immunoassay takes place in the wells of
the plate. Whereas, the LFIA, utilises multiple materials for the different compo-
nents of the test (see Chapter 4). Therefore, the plate immunoassay does not have
the additional challenges posed from material interference as in the LFIA. Hence
the plate assay allows for the fundamental principle of a competitive immunoassay
to be tested, i.e., whether TNT can be detected in a competitive immunoassay
format with the reagents that have been selected. The conditions of the reagents
of the immunoassay can also be optimised, which provides the optimum sensitiv-
ity of the assay that can be achieved with the selected conditions.
The competitive immunoassay used in this research aims to detect TNT in fin-
gerprint deposits. Detection of TNT in fingerprints offers a strong advantage as
it allows for the contaminated sample (fingerprint deposit) to be linked with the
identity of the handler. For example, techniques that detect TNT in swabbed
samples from luggage may identify the presence of TNT but do not account for
situations where luggage, or the contents of the luggage, may have been swapped.
Detection of TNT in fingerprints also has the added advantage of being a non-
invasive procedure.
As described in Chapter 1, there are various techniques in development for the
detection of TNT and explosive materials in fingerprints. To date, there have
been no literature reports demonstrating the detection of TNT in fingerprint de-
posits through an immunoassay technique. The primary focus of the literature
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has been to develop immunoassays which detect TNT in swab samples, such as
samples from luggage at airports; hand swabs; or environmental samples, such as
TNT contaminated soil or water. The large majority of literature on fluoroim-
munoassays is based on a flow through format, i.e., LFIA, which will be discussed
in Chapter 4. With regards to plate immunoassays, Fetterolf et al. [74] was the
first to demonstrate detection of TNT in hand swab samples, with a sensitivity
of 50 pg. The study used an enzyme-linked immunosorbent assay (ELISA). The
ELISA format is similar to the protocol in this research, with a protein-TNT con-
jugate immobilised on a plate and incubated with TNT and anti-TNT antibody.
The difference with the ELISA method is that it employs a secondary antibody
conjugated to an enzyme. The secondary antibody-enzyme conjugate binds to
any anti-TNT antibody that is bound to the immobilised TNT. Finally, an en-
zyme substrate is added to the system where it is bound by the enzyme. This
binding reaction results in a colour change that is indirectly proportional to the
concentration of free TNT in the sample. Hence, the reported ELISA is a colori-
metric method, i.e., absorbance is measured; whereas the method in this research
employs an antibody labelled with a fluorescent dye.
3.2 Aims of the Research Described in this Chap-
ter
Firstly, the aim of the research in this chapter is to demonstrate that it is possible
to detect TNT in a competitive immunoassay format. Secondly, the research aims
to find the optimal conditions of the different reagents to determine the sensitiv-
ity of the immunoassay. Thirdly, the research described in this chapter aims to
investigate the effect of the presence of a fingerprint deposit on the immunoassay
sensitivity.
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3.3 Results and Discussion
3.3.1 Unlabelled Anti-TNT Antibody Binding Specificity
All testing performed with the unlabelled anti-TNT antibody required an AF488
labelled secondary antibody, to provide a signal for detection. The first step was
to determine that the anti-TNT antibody recognised the bound form of the an-
alyte, i.e., BSA-TNT. This study was performed in a direct binding plate assay
and the results are shown in Figure 3.1. Figure 3.1 demonstrates that the anti-
TNT antibody recognises the BSA-TNT as when the antibody concentration is
increased, an increase in the fluorescence intensity is observed. The fluorescence
intensity is dependent on the amount of labelled secondary antibody bound, which
in turn is dependent on the amount of anti-TNT antibody bound to the BSA-
TNT. Hence, the more anti-TNT antibody bound to the BSA-TNT, the higher
the fluorescence intensity. Eventually the binding does become saturated and the
fluorescence intensity plateaus. This can be seen in Figure 3.1 as the steepness of
the slope reduces after 25 µg ml-1 of the anti-TNT antibody.
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Figure 3.1: Direct binding assay assessing the anti-TNT antibody binding to the BSA-
TNT. Wells were coated with 1 µg ml-1 of BSA-TNT. The anti-TNT antibody concen-
tration used was 0-100 µg ml-1. The secondary antibody concentration used was 50 µg
ml-1. Error bars represent standard deviation, n=3.
As the results shown in Figure 3.1 demonstrated that the anti-TNT antibody
recognises the bound TNT (BSA-TNT), the next step was to assess the abil-
ity of the anti-TNT antibody to bind to the free TNT (TNT). This study was
performed in a competitive plate assay. For a competitive plate assay, the fluo-
rescence intensity is indirectly proportional to the concentration of TNT. As the
TNT concentration is increased, more anti-TNT antibody is occupied by the free
TNT. Hence, fewer antibodies bind to the BSA-TNT and therefore there are fewer
sites for the labelled secondary antibody to bind to. However, as shown in Figure
3.2, there was no decrease in fluorescence intensity when the TNT concentration
was increased. This result could be due to a number of reasons. Firstly, it may
be that the anti-TNT antibody is in such excess that the anti-TNT antibody can
bind all the TNT available in the sample, and there still be enough unoccupied
anti-TNT antibody remaining to bind to the BSA-TNT. Secondly, there may be
non-specific binding from the secondary antibody, i.e., the secondary antibody is
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in such excess that it is binding to other components. This would result in the
secondary antibody masking any competition that may occur. Thirdly, the anti-
body may be recognising the BSA of the BSA-TNT conjugate, rather than the
TNT. The latter will be discussed in Section 3.3.3. All of these possibilities were
examined. Note that the anti-TNT antibody concentration used for the following
studies was 25 µg ml-1. This was because the 25 µg ml-1 concentration provided a
similar fluorescent intensity as the 100 µg ml-1 anti-TNT antibody concentration,
as shown in Figure 3.2. Lower anti-TNT antibody concentrations can increase
sensitivity of the assay as a lower TNT concentration is required to occupy the
anti-TNT antibody sites, and consequently to show reduced fluorescence signals,
i.e., competition. However, at too low a concentration of anti-TNT antibody the
fluorescence intensity can be too low for detection. Therefore, it was thought that
25 µg ml-1 of anti-TNT antibody concentration should be used as this concentra-
tion produces a similar fluorescence signal as that of the 100 µg ml-1, as shown in
Figure 3.2, but with the possibility of a greater sensitivity for the TNT.
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Figure 3.2: Competitive plate immunoassay testing the effect of anti-TNT concentration
on the sensitivity of the assay. The anti-TNT antibody concentrations used were: 0 µg
ml-1 (orange, dash dot line); 6.25 µg ml-1 (red, dashed line); 25 µg ml-1 (green, solid
line) and 100 µg ml-1 (blue, dash dot dot line). TNT concentration ranged between
0-1 µg ml-1. The secondary antibody concentration used was 50 µg ml-1. Error bars
represent standard deviation, n=3.
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Firstly, the TNT concentration was increased 10-fold to determine whether com-
petition could be seen. As shown in Figure 3.3, increasing the TNT concentration
did not show a decrease in the fluorescence intensity and hence, the immunoas-
say did not show competition. Next, different secondary antibody concentrations
were tested to assess whether the secondary antibody was in such excess that
it was non-specifically binding to the wells. As can be seen in Figure 3.4, both
concentrations of secondary antibody maintained relatively constant fluorescence
intensities, regardless of TNT concentration. This implies that reducing the sec-
ondary antibody concentration did not increase the assay sensitivity, nor display
any signs of competition. However, to completely rule out non-specific binding
by the secondary antibody, the anti-TNT antibody was labelled with the AF488
dye. Removal of the secondary antibody would also simplify the immunoassay by
reducing the number of steps in the immunoassay procedure, which could reduce
error.
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Figure 3.3: A competitive plate immunoassay to determine whether an increased TNT
(0-10 µg ml-1) concentration would improve sensitivity. The anti-TNT antibody concen-
tration was 25 µg ml-1 and the secondary antibody concentration was 50 µg ml-1. Error
bars represent standard deviation, n=3.
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Figure 3.4: Assessment of the effect of the secondary antibody concentration on the sen-
sitivity of the competitive immunoassay. The secondary antibody concentrations used
were: 10 µg ml-1 (red, dashed line) and 50 µg ml-1 (green, solid line). The TNT con-
centration ranged between 0-10 µg ml-1. The anti-TNT antibody concentration used was
25 µg ml-1. Error bars represent standard deviation, n=3.
3.3.2 Anti-TNT Antibody Labelling
The AF488 dye used to label the anti-TNT antibody is the same fluorophore that
was used to label the secondary antibody. An optimisation of the molar ratio of
the number of dyes labelled to anti-TNT antibody was performed. The spectra
obtained for each labelled anti-TNT antibody solution are shown in Figure 3.5.
The moles of labelled dye per mole of antibody were calculated (see Section 2.5)
giving rise to 13, 11, 9 and 3 moles of dye per 1 mole of anti-TNT antibody. These
ratios will be referred to as 13:1, 11:1, 9:1 and 3:1, respectively for the remainder
of this thesis. Table 3.1 summarises the conditions that were used to obtain the
13:1, 11:1, 9:1 and 3:1 labelled antibodies.
56
(a
)
00.10.20.30.40.5
26
5
29
0
31
5
34
0
36
5
39
0
41
5
44
0
46
5
49
0
51
5
Absorbance / AU
W
av
ele
ng
th
 / n
m
(b
)
00.10.20.30.40.5
26
5
29
0
31
5
34
0
36
5
39
0
41
5
44
0
46
5
49
0
51
5
Absorbance / AU
W
av
ele
ng
th
 / n
m
(c
)
00.10.20.30.40.5
26
5
29
0
31
5
34
0
36
5
39
0
41
5
44
0
46
5
49
0
51
5
Absorbance / AU
W
av
ele
ng
th
 / n
m
(d
)
00.10.20.30.40.5
26
5
29
0
31
5
34
0
36
5
39
0
41
5
44
0
46
5
49
0
51
5
Absorbance / AU
W
av
ele
ng
th
 / n
m
Fi
gu
re
3.
5:
T
he
ab
so
rb
an
ce
sp
ec
tra
(2
65
-5
15
nm
)
of
th
e
di
ffe
re
nt
A
F4
88
la
be
lle
d
an
ti-
T
N
T
an
tib
od
y
so
lu
tio
ns
.
T
he
m
ol
ar
ra
tio
s
of
la
be
lle
d
dy
e
pe
r
an
tib
od
y
of
ea
ch
so
lu
tio
n
ar
e:
(a
)
13
:1
;
(b
)
11
:1
;
(c
)
9:
1;
an
d
(d
)
3:
1.
T
he
la
be
lle
d
an
ti-
T
N
T
an
tib
od
y
so
lu
tio
ns
we
re
m
ea
su
re
d
at
th
e
fo
llo
wi
ng
co
nc
en
tra
tio
ns
,b
as
ed
on
th
e
an
ti-
T
N
T
an
tib
od
y
co
nc
en
tra
tio
n:
(a
)
0.
07
µg
m
l-1
;(
b)
0.
06
µg
m
l-1
;
(c
)
0.
09
µg
m
l-1
;a
nd
(d
)
0.
17
µg
m
l-1
.
57
Table 3.1: Summary of the conditions that provided the relative dye:antibody molar
ratios.
Dye:Molar
Ratio
[Dye] /
µgml-1
[Antibody]
/ mg ml-1
Time of Reaction
/ mins
Buffer
13:1 10 1.67 60 SBB pH
9.5
11:1 5 0.85 60 SBB pH
9.5
9:1 5 1.85 60 SBB pH
9.5
3:1 0.5 1.9 60 SBB pH
8.02
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It was important to assess the binding of the antibody after labelling as loss of
specificity for the analyte, aggregation and fluorescence quenching can all occur.
Loss of specificity would be as a result of the dyes attaching to the amino acids
which are important to the structure of the binding site of the antibody, and is
not necessarily restricted to those amino acids which comprise the binding site.
The highly specific interaction between the antibody and its corresponding ana-
lyte can easily be lost if the structure and bonds are altered. The dye can also
bind to the antibody in a manner which blocks the binding site from being able
to access the analyte. Hence, binding of the dyes to the antibody can alter the
antibody’s specificity through chemical and physical interference. The AF488 dye
is also highly hydrophobic and so over-labelling can lead to aggregation of anti-
bodies. The aggregated antibodies could impose competition by binding to each
other rather than the BSA-TNT and washing off the plate, consequently reducing
the fluorescence signal. Over-labelling can also result in the fluorescence signal
being quenched, due to the nature of the dyes self-quenching when in close prox-
imity of each other. In the protein labelling kit manual [67] it is reported that the
optimum moles of dye per mole of protein is 4-9:1. Therefore, the 13:1 and 11:1
labelled anti-TNT antibodies have slightly higher number of dyes than suggested.
Consequently, it is important to confirm the specificity of the antibody and to
ensure any competition shown isn’t due to quenching effects.
The labelled antibodies were all tested in a competitive plate immunoassay, shown
in Figure 3.6. The concentration of all antibodies was 25 µg ml-1, consistent with
the previous unlabelled antibody studies. The labelled antibodies: 13:1, 11:1 and
9:1 all showed a significant decrease in fluorescence intensity as the TNT con-
centration increased, and hence demonstrated competition. The 13:1 and 11:1
labelled antibodies showed the steepest slopes and therefore, the highest sensitiv-
ity. The 13:1 and 11:1 labelled antibodies were consequently used for all future
studies involving a labelled anti-TNT antibody. As stated above, the optimum
dye per mole of protein is 4-9:1. This is not consistent with the results shown
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in Figure 3.6, as the highest sensitivity was achieved with the 11:1 and 13:1, of
which both are above the optimal moles of dye to protein ratio. However, the pro-
tein labelling kit manual also states that different antibodies react with the dye
at different rates, along with the antibody binding specificity being maintained
with different numbers of labelled dyes to that of the suggested labelled moles of
dye to protein ratio (4-9:1) [67]. Hence, the 4-9:1 ratio may not be optimal for all
antibodies. In the ’troubleshooting’ section of the protein labelling kit manual,
increasing the amount of labelling is suggested. Therefore, it is not an unusual
result for a slightly higher moles of dye per mole of protein ratio, such as 11:1 and
13:1 to exhibit a higher sensitivity. In Figure 3.6, there is a trend of increasing
antibody specificity for TNT as the number of labelled dyes are increased. This
sensitivity plateaus at 11:1 and 13:1, as the antibodies have similar sensitivities.
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Figure 3.6: Optimisation of the moles of dye bound to the anti-TNT antibody. The
ratios of moles of dye per mole of antibody were: (a) 13:1 (green, solid line) and 3:1
(red, dashed line); and (b) 11:1 (blue, dashed line) and 9:1 (orange, dashed and dotted
line). The TNT reference concentration ranged from 0-10 µg ml-1. All antibodies were
added to the plate at a concentration of 25 µg ml-1. Error bars represent standard
deviation, n=3.
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3.3.3 Labelling Effects on the Anti-TNT Antibody Bind-
ing Specificity
Studies were first performed on the anti-TNT antibody’s ability to recognise the
bound form of the analyte, BSA-TNT. As shown in Figure 3.7, the anti-TNT an-
tibody preferentially binds to the BSA-TNT conjugate over the BSA. The binding
specificity of the unlabelled anti-TNT antibody to the BSA-TNT was compared
against the AF488 labelled anti-TNT antibody (13:1), which showed similar re-
sults. These results signified that labelling did not diminish the antibody’s ability
to recognise BSA-TNT. Hence, the no competition seen with the unlabelled an-
tibody studies (Section 3.3.1) was not due to the anti-TNT antibody binding to
the BSA.
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Figure 3.7: Assessment of the binding specificity of the anti-TNT antibody to the BSA-
TNT, before and after labelling. Wells were coated with either 1 µg ml-1 of BSA or
BSA-TNT. Either 25 µg ml-1 of unlabelled (red bars) or AF488 labelled (blue, dashed
bars) anti-TNT antibody was added to the coated wells. The labelled antibody used had a
molar dye to protein ratio of 13:1. For the unlabelled antibody, 50 µg ml-1 of an AF488
labelled secondary antibody was added. Before addition of each antibody, the wells were
washed with 100 µl of 10 mM phosphate buffer, 80 mM NaCl and 0.22 mM Tween 20
(PBST) pH 7.4, three times. Error bars represent standard deviation, n=3.
3.3.4 Fluorescence Quenching Effects by TNT
Quenching studies were performed as described in Section 2.2.3. The highly elec-
trophilic nature of the TNT molecule can result in its ability to quench fluo-
rophores by accepting the excited electrons [75]. Additionally, it is possible that
the TNT could bind to the BSA-TNT or the plate, or both, regardless of blocking
steps. Therefore, there was a concern that the competition shown in Figure 3.6
was a result of the TNT quenching of the AF488 dye. If this were true, there
would be a decrease in fluorescence signal emitted from the AF488 dye, as the
TNT concentration increased. In Figure 3.8 there is no significant decrease in flu-
63
orescence intensity the TNT concentration was increased. Furthermore, as shown
in Figure 3.6, competition is observed at 0.16-0.63 µg ml-1 for the 13:1 labelled
antibody. If this competition were a result of TNT quenching the fluorescence
signal, it would be expected that a significant decrease of fluorescence at this con-
centration of TNT would be observed in Figure 3.8 as well. Since no fluorescence
quenching is observed in Figure 3.8, the decrease in fluorescence signal shown in
the competitive assays (Figure 3.6) is not due to quenching effects of the TNT.
The quenching is instead due to the competitive binding of the antibody to the
free TNT and bound TNT. This suggests that the labelling of the antibody has
either increased the specificity of the anti-TNT antibody to detect TNT, reduced
non-specific binding effects from the secondary antibody or, more likely, a mixture
of both. Therefore, the labelled anti-TNT antibody will be used to optimise the
conditions of the TNT competitive assay to increase the assay sensitivity.
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Figure 3.8: Assessment of the fluorescence quenching of the AF488 labelled anti-TNT
antibody in the presence of increasing TNT concentrations (0-10 µg ml-1). Labelled
anti-TNT antibody (13:1) was added to the plate at 25 µg ml-1. Error bars represent
standard deviation, n=3.
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3.3.5 TNT Solubilisation Buffer Optimisation
The first step of the competitive immunoassay optimisation is to ensure that
there is maximum solubilisation of the TNT, whilst maintaining a buffer that is
compatible with the other components of the assay, such as prevention of antibody
denaturation. If the TNT is solubilised then it is more accessible for binding by
the antibody, which means that lower concentrations of TNT can be detected,
i.e., increased sensitivity. Note that for all optimisation experiments, the buffer
providing the highest sensitivity was carried through for comparison against the
following set of conditions. It has been shown in Chen et al. [76] that addition of
methanol to TNT diluent can increase its solubility. Figure 3.9 shows the results
from the competitive assays that have 10 mM phoshate buffer (PB) plus varying
methanol concentrations (0%, 10% and 50%). It can be seen in Figure 3.9a that
immunoassay competition occurs at 0.16-0.63 µg ml-1 when TNT is solubilised
in PBST (original conditions). However, solubilising the TNT in PB with 10%
methanol increases the sensitivity of the assay to 0.04-0.16 µg ml-1 (Figure 3.9b).
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Figure 3.9: Optimisation of TNT reference solution diluent. Conditions in (a) represent
phosphate buffer (red, dashed line) Vs. PBST (green, solid line) and (b) shows PB with
10% methanol (orange, dash dotted line) Vs. PB with 50% methanol (blue, dashed line).
Labelled antibody (13:1) was added to the plates at 25 µg ml-1. All conditions were tested
on the same plate but separated in Figures (a) and (b) for easier interpretation. Error
bars represent standard deviation, n=3.
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Next, different Tween 20 concentrations were tested against 10 mM PB with 10%
methanol. Tween 20 is a non-ionic surfactant. As reported by Linke [77], surfac-
tants are used to lower a liquid’s surface tension and the tension at the interface
between two liquids. Surfactants are organic compounds with a hydrophobic ’tail’
and hydrophilic ’head’. Tween 20 has a polysorbate head and a linear fatty acid
chain tail. As the chain length is increased, so is the hydrophobicity of the surfac-
tant. At a given concentration, the surfactant monomers aggregate into a spherical
form, called a micelle. The concentration at which the surfactant forms micelles
is called the critical micelle concentration (CMC) [78]. Micelles form around the
hydrophobic molecules in aqueous solution, which can be a problem for small
molecules, such as TNT, because the micelles may block the antibody from being
able to access the TNT for binding. However, pH, temperature and salt con-
centration can all affect the CMC as well as directly affecting the solubility of
the solute, i.e., TNT, themselves. Therefore, it is important to test a range of
surfactant concentrations to find the optimal solubility conditions. The Tween
20 concentration in the original solubilisation buffer, i.e., PBST, was 0.22 mM.
A range of Tween 20 concentrations were tested in 10 mM PB, these included:
the CMC (0.06 mM), and then double (0.12 mM) and half (0.03 mM) the CMC
of Tween 20. The different solutions were tested against the 10 mM PB with
10% methanol, and the results are shown in Figure 3.10. The conditions that
provided the highest sensitivity was the 10 mM PB with 0.12 mM Tween 20, with
immunoassay competition observed at 0.01-0.04 µg ml-1. Note that at this stage,
to conserve antibody, the antibody concentration was reduced to 6.25 µg ml-1.
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Figure 3.10: Optimisation of TNT reference solution diluent. Conditions in (a) repre-
sent 10 mM PB with 0.12 mM Tween 20 (green, solid line) Vs. 10 mM PB with 0.03
mM Tween 20 (red, dashed line) and (b) shows 10 mM PB with 0.06 mM Tween 20
(blue, dashed line) Vs. 10 mM PB with 10% methanol (orange, dash dotted line). La-
belled antibody (13:1) was added to the plates at 25 µg ml-1. All conditions were tested
on the same plate but separated in Figures (a) and (b) for easier interpretation. Error
bars represent standard deviation, n=3.
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The last component of the original PBST solution was sodium chloride (NaCl) at
80 mM. A range of NaCl concentrations were tested and the results are shown in
Figure 3.11. The solutions tested were 10 mM PB with 0.12 mM Tween 20 and
0, 20, 40 or 80 mM NaCl. The optimal condition was 10 mM PB with 0.12 mM
Tween 20 and 40 mM NaCl. This is because the buffer with 40 mM NaCl has
the highest sensitivity, showing competition at 0.05-0.2 µg ml-1. It was shown by
Luning Prak [79] that the addition of Tween 80 increased solubility of the TNT.
Tween 80 is similar in structure to Tween 20, in that they both share a polysorbate
head. However, Tween 80 has a longer, unsaturated fatty acid chain [77] making it
a more hydrophobic surfactant. The Tween 80 was compared against Tween 20 in
the TNT solubilisation buffer. The concentrations of Tween 80 were at the CMC
(0.012 mM), half (0.006 mM) and double (0.024 mM) the CMC. The results are
shown in Figure 3.12. It is difficult to see any improvement on the sensitivity with
the addition of Tween 80. Therefore, the 10 mM phosphate buffer with 40 mM
NaCl and 0.12 mM Tween 20 (pH 7.4) solubilisation buffer was taken through to
the full plate optimisation studies.
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Figure 3.11: Optimisation of TNT reference solution diluent. Conditions in the figures
represent 10 mM PB with 0.12 mM Tween 20 with different sodium chloride (NaCl)
concentrations: (a) represent 0 mM (green, solid line) Vs. 40 mM (red, dashed line);
and (b) shows 20 mM (orange, dash dotted line) Vs. 80 mM (blue, dashed line). Labelled
antibody (13:1) was added to the plates at 6.25 µg ml-1. All conditions were tested on
the same plate but Figures separated in (a) and (b) for easier interpretation. Error bars
represent standard deviation, n=3.
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Figure 3.12: Optimisation of TNT reference solution diluent. The solubilisation buffers
used were 10 mM PB with 40 mM NaCl with different concentrations of either Tween 20
or Tween 80: (a) represent 0.12 mM Tween 20 (red, dashed line) Vs. 0.006 mM Tween
80 (green, solid line); and (b) shows 0.012 mM Tween 80 (orange, dash dotted line) Vs.
0.025 mM Tween 80 (blue, dashed line). Labelled antibody (13:1) was added to the plates
at 6.25 µg ml-1. All conditions were tested on the same plate but Figures separated in
(a) and (b) for easier interpretation. Error bars represent standard deviation, n=3.
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3.3.6 Plate Immunoassay Optimisation
Using the newly optimised solubilisation buffer (10 mM PB, 40 mM NaCl, 0.12
mM Tween 20, pH 7.4), a full optimisation of all plate immunoassay conditions
was performed. This involved different BSA-TNT concentrations (0.25, 0.5, 1
and 2 µg ml-1); different 13:1 antibody concentrations (0.39, 1.56 and 6.25 µg
ml-1) with a range of TNT concentrations (0 - 0.5 µg ml-1). Figure 3.13 compares
the set of plate immunoassay conditions used in the solubisation buffer optimisa-
tion (BSA-TNT concentration at 1 µg ml-1; anti-TNT antibody concentration at
6.25 µg ml-1) against the set of the conditions from the full plate immunoassay
optimisation that shows the highest sensitivity (BSA-TNT concentration at 0.5
µg ml-1; anti-TNT antibody concentration at 6.25 µg ml-1). Both sets of condi-
tions provide a limit of detection at 0.03 µg ml-1. Hence, there is no difference in
sensitivity between the conditions used in the solubilisation buffer optimisation
studies and the best conditions from the full plate immunoassay conditions.
The BSA-TNT and anti-TNT antibody concentrations were fine tuned with one
another to provide optimal results. It is worth noting that lower anti-TNT anti-
body concentrations provide more sensitive results. As stated previously, in order
to detect a fluorescence signal, the anti-TNT antibody must be bound to the BSA-
TNT to prevent the anti-TNT antibody from being washed off the plate. If there
are lower antibody concentrations, lower TNT concentrations are required to oc-
cupy the antibody binding sites, lowering the available anti-TNT antibody that
can bind to the BSA-TNT. Hence, lower antibody concentrations require lower
TNT concentrations to demonstrate a significantly lower fluorescence signal, and
therefore improved sensitivity. However, lowering the antibody concentration too
far can result in low fluorescence intensities, with undetectable fluorescence in-
tensity changes. On top of this, the BSA-TNT concentration can also affect the
fluorescence intensity and the sensitivity of the assay. The higher the BSA-TNT
concentration, the more sites available for the antibody to bind too. This means
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there is higher fluorescence signals with higher BSA-TNT concentrations. Increas-
ing the BSA-TNT concentration above a certain point can improve sensitivity, as
there are greater differences in fluorescence signals with increasing TNT concen-
trations. However, lower BSA-TNT concentrations result in lower available sites
for the unoccupied anti-TNT antibody to bind too, which again can improve sen-
sitivity of the assay. Hence, the results shown in Figure 3.13 suggest that the
original conditions using the optimised solubilisation buffer, provide optimal con-
ditions as sensitivity was not significantly improved with any other conditions
tested. Hence these conditions were taken forward.
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Figure 3.13: Optimisation of the TNT competitive plate assay conditions. The set of
conditions used in the optimised solubilisation buffer studies are represented by the red,
dashed line (BSA-TNT and anti-TNT antibody concentrations were 1 µg ml-1 and 6.25
µg ml-1, respectively). The set of conditions which provided the highest sensitivity in
the full plate immunoassay studies are represented by the green, solid line (BSA-TNT
and anti-TNT antibody concentrations were 0.5 µg ml-1 and 6.25 µg ml-1, respectively).
Error bars represent standard deviation, n=3.
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3.3.7 Competitive Plate Assay using TNT Spiked Finger-
prints
In this research, the final immunoassay should be able to detect TNT from a con-
taminated, deposited fingerprint. Fingerprints were introduced to check that the
fingerprint deposit does not interfere with the assay, for instance the anti-TNT
antibody may non-specifically bind to components in the fingerprint deposit. Any
interference caused by the fingerprint can result in loss of sensitivity or ’false’ posi-
tives, and hence, it is important to test at an early stage in the assay development.
As described in Section 2.2.4, non-contaminated fingerprints were deposited onto
glass slides and then extracted. Known TNT reference solutions (0-8 µg ml-1) were
added to the extracted fingerprint solutions. Fingerprints that have the addition
of a known concentration of TNT are referred to as ’spiked’ fingerprints. A control
set of TNT standards (without fingerprint addition) were tested alongside. The
results are shown in Figure 3.14. The data was analysed with the four parameter
logistic nonlinear regression model using SigmaPlot and the IC50 was calculated.
The IC50 of the TNT solutions in the presence of fingerprints was 0.19 µg ml-1 of
TNT; whereas, the IC50 with the TNT solutions in the absence of fingerprints was
0.38 µg ml-1 of TNT. The lower IC50 value of the TNT solution in the presence of
fingerprints means that lower concentrations of TNT are required to cause 50%
inhibition of the anti-TNT antibody binding. Therefore, lower IC50 value demon-
strates that the fingerprint does show some inteference of the immunoassay. The
inteference is likely to be from non-specific binding by the anti-TNT antibody to
the components in the fingerprint residue. The implication of non-specific bind-
ing of the anti-TNT antibody to the fingerprint residue is that the use of this
antibody in a test could provide false positives. The non-specific binding effect
should be taken into account when developing the lateral flow immunoassay test.
Larger sample sizes, testing the variability and effect of the non-specific anti-TNT
antibody should be assessed.
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Figure 3.14: Testing the effect of the addition of fingerprints on the sensitivity of the
TNT competitive assay. The TNT reference solutions either contained extracted fin-
gerprint (red squares) or no fingerprint (black squares). Error bars represent standard
deviation, n=3. The fitted curves for the TNT reference solutions containing extracted
fingerprints (green line) and without fingerprints (purple line) were calculated with a
four parameter logistic nonlinear regression model using SigmaPlot. The IC50 of the
TNT solution containing fingerprints is represented by a blue triangle and the IC50 of
the TNT solutions without fingerprints is represented by a grey traingle.
3.4 Conclusions
The primary aim of the research presented in this chapter was to demonstrate
that TNT can be detected in a competitive plate fluoroimmunoassay. This aim
has been achieved successfully. The anti-TNT antibody was first shown to recog-
nise the bound form of TNT, i.e., BSA-TNT. The next step demonstrated issues
with the anti-TNT antibody recognising the free form of the TNT. The anti-TNT
antibody was labelled with Alexa Fluor 488 dye to remove the requirement of the
secondary antibody. This was done to reduce any effects of non-specific binding
from the secondary antibody, which could mask any competition. The removal of
the secondary antibody also reduced error from decreasing the number of steps
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required in the assay. It was found that sensitivity of the assay was improved with
removal of the secondary antibody, and increasing the ratio of moles of labelled
dye to mole of anti-TNT antibody. The optimal ratio of moles of labelled dye to
anti-TNT antibody was found to be between 11-13:1, both displaying the same
limit of detection in the presence of TNT at 0.63 µg ml-1. The binding specificity
for the BSA-TNT conjugate was assessed after labelling, where no statistically sig-
nificant difference in binding specificity was observed before and after labelling.
TNT was then tested for any fluorescent quenching effects on the AF488 dye that
is used to label the anti-TNT antibody. No fluorescence quenching was observed,
which meant that any decrease in fluorescence seen with the addition of TNT
is due to the competitive binding of the anti-TNT antibody for the BSA-TNT
and TNT. Consequently, higher TNT concentrations resulted in lower anti-TNT
antibody concentrations bound to the BSA-TNT. To improve sensitivity, the sol-
ubilisation buffer composition, BSA-TNT and anti-TNT concentrations, i.e., the
immunoassay reagents, were optimised. Firstly, different compositions of the TNT
solubilisation buffer were tested, including different surfactants (Tween 20 and
Tween 80), salt (NaCl) and methanol concentrations. The optimal solubilisation
buffer composition was found to be 10 mM phosphate buffer, 40 mM NaCl and
0.12 mM Tween 20, pH 7.4, as the solubilisation buffer provided the results with
the lowest limit of detection at 0.05 µg ml-1. After this, the anti-TNT antibody
and BSA-TNT concentrations were optimised, to provide the optimal sensitivity.
The concentrations which provide the highedst sensitivity were 6.25 µg ml-1 for
the anti-TNT antibody and 1 µg ml-1 for the BSA-TNT. This provided a limit of
detection at 0.03 µg ml-1.
The immunoassay developed in this research is to be used in the detection of TNT
in fingerprints. However, a critical finding from the fingerprint studies showed that
lower concentrations of TNT were required to inhibit anti-TNT antibody binding
to BSA-TNT by 50% in the presence of fingerprints when compares to TNT so-
lutions without fingerprints. Therefore, the presence of fingerprints would falsey
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imply more TNT was present in the sample than there would be. The non-specific
binding of the anti-TNT antibody to the fingerprint residue should be taken into
consideration during development of the lateral flow immunoassay (LFIA).
77
Chapter 4
Developing a Lateral Flow
Immunoassay Test Using a
Competitive Binding Format
The plate immunoassay studies described in Chapter 3 have demonstrated that
the antibody recognises TNT with a limit of detection of 0.03 µg ml-1. The TNT
sample volume used in the competitive plate immunoassay is 10 µl , and so that
equates to a sensitivity of around 300 pg per fingerprint deposit. Therefore, Chap-
ter 3 has demonstrated that TNT can be detected with a competitive immunoas-
say technique. However, the plate immunoassay method does not offer the many
advantages of the lateral flow immunoassay (LFIA) format; which are that the
LFIA is quick, portable, cheap and easy to use. There are elements that can be
carried foward from the plate immunoassay studies in Chapter 3 to the LFIA.
Firstly, a functioning, labelled anti-TNT antibody that recognises the BSA-TNT
and TNT has been demonstrated for use in a competitive immunoassay format.
Secondly, the solubilisation buffer has shown to be compatitable for anti-TNT
antibody and TNT solubilisation, and so, can be used for solubilisation of the
reagents in the LFIA. However, different volumes of the reagents are required for
the LFIA along with different materials; and hence, further optimsiation of the
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competitive immunoassay in the LFIA format will be required.
The research described in this chapter begins by employing a direct wick for-
mat. This simplifies the test set-up, only using a test strip and adsorbent pad,
which may remove possible interference challenges that may arise with the full,
LFIA assembly. Firstly, the test strip blocking conditions were optimised, test-
ing different compositions. Secondly, there was comparison between the plate
immunoassay and direct wick format to ensure the reaction could occur using
the same conditions as the direct wick, i.e., at room temperature and within four
minutes. Next, the optimal BSA-TNT concentration was selected to provide max-
imum sensitivity. Finally, the conditions optimised on the test strip were tested
using a LFIA system, i.e., with full assembly of components and in a cassette.
The fluorescence of the test (BSA-TNT) and control (horse anti-mouse antibody)
lines were measured using a Qiagen Lateral Flow Reader, and the test strip was
fluorescently imaged in an Optical Breadboard Imaging Device designed by EG
Technology.
This chapter will begin with an introduction to the LFIA technique used in the
research and the strengths of the LFIA format over the plate immunoassay. This
will be followed by a brief look at the research published and then the aims of this
chapter. The results obtained during the research will be discussed and finally a
section on the conclusions drawn from the research findings.
4.1 Introduction
A LFIA simplifies the competitive immunoassay procedure shown in the plate im-
munoassay studies in Chapter 3. The test is performed along a single axis with the
use of a porous membrane and designed to demonstrate if the analyte of interest
(TNT) is present in a sample [80]. In LFIA, the solution moves through the system
via capillary action, described as ’wicking’ from here on in [81]. The LFIA format
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is often used for diagnostic and detection tests, due to the many advantages it
can offer. The high affinity nature of the interaction between the antibody and its
corresponding analyte can result in a sensitive detection method. The sensitivity
between different immunoassays can vary, as the sensitivity is largely determined
by the binding affinity of the antibody with the analyte. As different immunoas-
says employ different antibodies with varying binding affinities, the sensitivity of
an immunoassay differs between different analytes. The highly specific interaction
between the antibody and its analyte means that sample preparation is usually
not required, as other components in the sample should not interfere with the
functioning of the assay. Without the need for sample preparation, the procedure
and equipment required for testing is simplified, allowing non-specialised person-
nel to operate the test. It is important for a test to be easy-to-use if the test is to
be applicable for use in a diverse range of environments. Although the primary
use for the TNT LFIA test may be in security settings, the test could also be used
in health monitoring applications. For example, one situation may be to monitor
employees who are based in the manufacture of TNT products, such as munition
factories, to ensure they have not been exposed to dangerous levels or accidental
contamination of TNT.
In this research, the LFIA is composed of a number of materials: a sample pad,
conjugate pad, test strip and adsorbent pad. The assembled components are en-
cased in a plastic cassette (see Figure 2.3 in Section 2.4). A TNT-contaminated
fingerprint is deposited onto the sample pad. Soubilisation buffer is then added
to the sample pad. The buffer wicks through the sample pad solubilising the
TNT in the fingerprint deposit. The conjugate pad contains the AF488 labelled
anti-TNT antibody. The solubilised TNT moves with the buffer into the conju-
gate pad, where the anti-TNT antibody is solubilised. The TNT and anti-TNT
antibody then move along the test strip. The test strip is a porous membrane
(nitrocellulose) that has a test line (BSA-TNT) and a control line (horse anti-
mouse antibody) deposited. As the anti-TNT antibody and the TNT wick along
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the test strip, the anti-TNT antibody binds the TNT. As the solubilisation buffer
passes over the test and control lines, any unbound anti-TNT antibody binds to
the BSA-TNT (test line). The control line is composed of horse anti-mouse which
binds any mouse antibody, TNT occupied or not. Therefore, the control line is
used to confirm that the antibody has passed through the system. Note that the
adsorbent pad functions to draw up the liquid through the test and prevent flow
back down the strip [62]. The LFIA therefore employs the same principle as the
plate immunoassay; as the free TNT concentration is increased, the lower the flu-
orescent signal emitted. Figure 4.1 summarises the LFIA mechanism. Note that
4.1 is shown without the cassette for easier interpretation; in the LFIA studies
described in this chapter, the LFIA componenets are encased in a plastic cas-
sette. In the LFIA reported in this chapter, the fluorescence signal is measured
with a Qiagen ESEQuant Lateral Flow Reader. This uses a light emitting diode
(LED) excitation and a photodiode detector. Hence, the fluorescence intensity
corresponds to the voltage produced for the area measured (mm*mV) on the test
strip.
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Figure 4.1: A schematic diagram summarising the LFIA mechanism used in this re-
search. Note that in the LFIA studies described in Chapter 4, the LFIA components
will be encased by a cassette. The assembled test is shown in (a). In (b), the solubilisa-
tion buffer has been added to the sample pad and has wicked along the test, solubilising
the TNT in the deposited sample and anti-TNT antibody from the conjugate pad. The
solubilised antibody and TNT interact as they move along the test strip. Three possi-
ble results from the LFIA have been shown in (c): the antibody bound to the test line
(BSA-TNT); the antibody bound to the control line (horse anti-mouse antibody); and
the antibody bound to the free TNT in the deposited sample, that has wicked through the
adsorbent pad.
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In comparison to the plate immunoassay format, the LFIA provides a better op-
tion for a test. Firtsly, the plate immunoassay takes ~3 hours for completion and
involves a more complicated, laboratory-based procedure, that would require a
higher level of training in comparison to the LFIA. The simplicity of the LFIA
test will also improve the speed at which the test can be carried out, together
with requiring minimal training. The design of the LFIA means that the test is
portable, and hence allows for the test to be used in a wide range of settings.
Results can also be obtained in minutes with a LFIA test, obtaining results in
8 minutes within the research described in this chapter. It is important for the
test be fast if it is to be used in environments where large sample sets need to
be tested as quick as possible, such as airports. The LFIA also has the added
advantage of being relatively cheap to produce [81].
With reference to this research, the LFIA test developed aims to detect TNT
through a fingerprint deposit. As stated in Chapter 3, this mechanism is non-
invasive, and through fingerprint identification, it can provide a method of linking
the handler to the deposited TNT-contaminated fingerprint. Although there has
been research conducted for the detection of TNT through LFIAs, to date, there
have been no literature reports demonstrating the detection of explosive materi-
als in fingerprints using a LFIA mechanism. The focus of the LFIA research for
explosive detection has been with contaminated environmental samples or from
swabbed samples. In 2009, Maiolini et al. [82] developed a chemilluminescent based
LFIA for the detection of TNT, also using a secondary antibody labelled with gold
nanoparticles. The LFIA developed by Maiolini et al. [82] had a detection limit of
1 µg ml-1. In 2010, Girotti et al. [83] demonstrated a LFIA test using a secondary
antibody labelled with colloidal gold. The assay used swabbed samples containing
TNT, and achieved a sensitivity of 1 µg ml-1. In 2012, Mirasoli et al. [84] developed
an enzyme-based chemmilluminescent LFIA [84], that obtained a limit of detection
of 0.2 µg ml-1. The enzyme-based chemmiluminescent LFIA was also field deploy-
able as the chemmilluminescence signal was measured by an imaging device that
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was portable [84]. In 2015, Romolo et al. [85] demonstrated the use of the LFIA
techniques developed by Girotti et al. [83] and Mirasoli et al. [84] for the detection
of TNT in contaminated soil samples and swabbed hand samples. The technique
developed by Girotti et al. [83] achieved a limit of detection of 1 µg ml-1, and the
technique developed by Mirasoli et al. [84] achieved a limit of detection of 0.5 µg
ml-1, with the extracted TNT contaminated soil and hand swab samples. An ex-
cellent review by Smith et al. [81] discusses the immunoassay techniques developed
for the detection of explosive materials. In the review by Smith et al. [81], a LFIA
technique by DSTL is described that utilises a LFIA technique to detect TNT
from swabbed samples, however the immunoassay sensitivity is not discussed.
4.2 Aims of the Research Described in this Chap-
ter
In this chapter, the first aim was to demonstrate that the competitive immunoas-
say optimised in the plate immunoassay (see Chapter 3) can be applied to a lateral
flow mechanism, i.e.,demonstrate using the direct wick method. The second aim
was to introduce the LFIA components to produce a portable LFIA test for the
detection of TNT in fingerprint deposits.
4.3 Results and Discussion
4.3.1 Direct Wick Studies
The LFIA format uses different stationary phase materials, e.g., nitrocellulose,
which have different treatments and therefore different properties compared to
the plate assay. This can mean that a re-optimisation of the conditions are re-
quired for the analyte to remain soluble and accessible for binding by the antibody.
The direct wick format was employed to remove all materials (sample pad, con-
jugate pad) except for the nitrocellulose, i.e., the test strip and the adsorbent
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pad. There are different materials that can be used for the sample pad and the
conjugate pad. The role of the sample pad is to provide a platform for analyte
deposition and then solubilisation of the analyte. The conjugate pad contains the
antibody. Both the analyte and the antibody have to be combined in the solubil-
isation buffer to allow for interaction and binding. This requires the analyte to
be solubilised and moved through the sample pad and then through the conju-
gate pad, where the antibody can be solubilised so that they can interact whilst
moving through the test strip. These factors can require additional optimisation
to ensure the analyte can be efficiently solubilised from the sample pad, such as
alteration to the solubilisation buffer. Therefore, the direct wick format removes
these additional factors as the antibody and analyte solution are premixed before
being added to the test strip. As the premixed antibody and analyte solutions are
added directly to the test strip, this also removes interactions which affect analyte
or antibody solubility and ease of movement through the assay components.
Firstly, the optimised plate assay conditions (see Table 4.1) were replicated in
the direct wick format, which can be seen in Figure 4.2. Neither a control line nor
a test line was observed, yet a fluorescent area can be seen at the bottom of the
test strip. The fluorescent area was the antibody, which suggests the premixed
solution has not moved through the test strip. One reason for the solution unsuc-
cessfully wicking along the test strip may be because of non-specific binding to
the test strip by the antibody and the analyte in the premixed solution.
Table 4.1: Optimised Plate Assay Conditions
Reagent Optimised Condition
[BSA-TNT] 1 µg ml-1
[Labelled Anti-TNT Antibody] 6.25 µg ml-1
Solubilisation Buffer 10 mM PB, 40 mM NaCl, 0.12 mM Tween
20 (pH 7.4)
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0 0.16 0.63 2.5 10
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Estimated Area of Test Line 
Figure 4.2: Fluorescent images of the test strips from the direct wick assay with the op-
timised plate assay conditions is measured using the Optical Breadboard Imaging Device
designed by EG Technology. The exposure of the images was at 1 s. TNT concentration
increases from 0 to 10 µg ml-1, from left to right. The estimated areas of the control
(HAM) and test (BSA-TNT) lines are indicated with arrows.
Nitrocellulose is a membrane that binds proteins and so non-specific binding by
the antibody is an expected effect. Wetting agents may also need to be employed
to encourage movement of the solution through the test strip. Wetting agents,
such as surfactants, lower the surface tension and allow the solution to spread more
easily across the surface [86]. As reported by Liu et al. [87] and Mirasoli et al. [84],
BSA was used in the TNT solubilisation buffer at 0.1% and 3%, respectively.
BSA is used as a blocking agent by physically blocking non-specific binding by
binding to the membrane itself. A wetting agent that also has blocking properties
is polyvinylpyrrolidone (PVP). Therefore, a number of different conditions were
tested. The nitrocellulose was blocked with 10 mM phosphate buffer with either
0.1% BSA, 0.1% PVP or 3% PVP (pH 7.4) for 20 minutes; or the nitrocellulose
received no treatment, denoted as ’None’ in Figure 4.3. Each condition was then
tested with either the original solubilisation buffer (Table 4.1); or solubilisation
buffer with the addition of 3% BSA, denoted a in Figure 4.3. The results are
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summarised in Figure 4.3. There were only two blocking conditions that did not
display a control line, both used the original solubilisation buffer: the nitrocellu-
lose that did not receive any blocking application; and nitrocellulose blocked with
0.1 % BSA. Although, the fluorescent area (antibody) has clearly wicked further
along the nitrocellulose with the addition of 0.1% BSA as a blocking buffer. The
remaining conditions all displayed a control line. No test line was observed with
any of the conditions, suggesting that the BSA-TNT concentration was too low
to produce a detectable signal. Increasing the BSA-TNT concentration should
provide more binding sites for the unoccupied anti-TNT antibody to bind too,
therefore increasing the fluorescence signal from the test line. Three of the condi-
tions were taken forward for further investigation: 10 mM phosphate buffer with
either 0.1% BSA, 0.1% PVP and 3% PVP.
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The faintness or absence of the test line signal from Figure 4.3 suggested that
the BSA-TNT concentration was too low. The anti-TNT antibody binds to the
BSA-TNT. Lower BSA-TNT concentrations result in lower concentrations of anti-
TNT antibodies being able to bind to the test line. As the labelled dye is bound
to the anti-TNT antibody, lower concentrations of anti-TNT antibody bound
to the test line result in a lower fluorescence signal detected. When the BSA-
TNT concentration is too low, a fluorescence signal can not be detected above
the background level, as in Figure 4.3. Therefore, the BSA-TNT concentration
was increased from 1 µg ml-1 (as in the plate assay) to 5 µg ml-1. From the results
presented in Figure 4.3, the following nitrocellulose blocking conditions were taken
forward: 10 mM PB with either 0.1% PVP, 3% PVP or 3% BSA, pH 7.4. Premixed
solutions containing 6.25 µg ml-1 anti-TNT antibody (13:1) with different TNT
concentrations (0, 0.63, 2.5 and 10 µg ml-1) were wicked along the test strips and
the results are shown in Figure 4.4. The optimal nitrocellulose blocking condition
was the 10 mM PB with 3% PVP as this provided more consistent background
levels when compared to 0.1% PVP, and higher test line signals when compared
to the 3% BSA blocked strips. The reduced test line signals that occurred when
the nitrocellulose was blocked with 10 mM PB with 3% BSA, may be a result of
the BSA physically blocking the binding between the antibody to the test line.
Therefore, the nitrocellulose blocking conditions used from this point forward
were: 10 mM PB with 3% PVP, pH 7.4. From the fluorescent images obtained
with the Optical Breadboard Imaging Device (designed by EG Technology) and
shown in Figure 4.4, it is clear that both the control and test lines are visible in
all of the conditions. However, there was not a significant decrease of the test
line fluorescence signal observed with increasing TNT concentrations with the
readings from the ESEQuant Lateral Flow Reader.
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Figure 4.4: Fluorescent images of the test strips measured with the Optical Breadboard
Imaging Device (EG Technology) and readings using the ESEQuant Lateral Flow Reader
of the test strips from the direct wick assay results, with an increased BSA-TNT con-
centration of 10 µg ml-1. Different nitrocellulose blocking solution were tested, which
consisted of 10 mM PB with: (a) 0.1% PVP; (b) 3% PVP and (c) 3% BSA. The
control line (horse anti-mouse antibody) is the blue, dashed line and the test line (BSA-
TNT) is the red, solid line on the graphs. Image exposure = 1 s. Error bars representing
standard deviation, n=3.
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One possibility for the loss of competition in the direct wick format may be the
different temperature and time available for the reagents (antibody and analyte)
to interact. In comparison to the plate immunoassay, the direct wick format is
performed at a lower temperature (room temperature as oppose to 37oC in the
plate immunoassay) and the reagents have a shorter time period (four minutes as
oppose to one hour in the plate assay) to interact, which may affect the binding
kinetics between the anti-TNT antibody and the TNT, and account for the loss
of sensitivity in the direct wick experiment. The research described in Chapter
3 demonstrated that a competitive plate immunoassay format could successfully
detect TNT. To test whether the loss of sensitivity in the direct wick format is due
to the time and temperature at which the anti-TNT antibody and TNT interact, a
plate immunoassay was performed under direct wick conditions. The competitive
plate immunoassay procedure followed the same format as described in Section
2.2.2, except that 20 µl of a premixed solution (containing anti-TNT antibody
and TNT) was added to the wells for four minutes (instead of one hour, as in the
competitive plate immunoassay format described in Section 2.2.2) and at room
temperature (instead of 37oC, as in the competitive plate immunoassay format
described in Section 2.2.2). A range of BSA-TNT concentrations were tested in
the plate immunoassay. A direct wick experiment was performed at the same
time as the plate immunoassay and the results are shown in Figure 4.5. The test
strips from the direct wick experiment were fluorescently imaged using an Optical
Breadboard Imaging Device (EG Technology) and the fluorescence of the test and
control lines were measured in the ESEQuant Lateral Flow Reader. The plate
from the plate immunoassay was measured in a CLARIOStar Plate Reader. The
results in Figure 4.5 show that a significant decrease in fluorescence signal in the
presence of 10 µg ml-1, i.e., competition, was observed in the plate immunoassay
but not in the direct wick format. The anti-TNT antibody and TNT solution
interacted for four minutes at room temperature in both the direct wick and plate
immunoassay, therefore, the loss of sensitivity in the direct wick experiments was
not due to a difference in binding kinetics between the two assay formats. An
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important finding from these results is that the competition seen in the plate
immunoassay demonstrates that, in principle, a test can be performed at room
temperature and within four minutes. However, in practice, the immunoassay
would take a longer time since the wash solution is required to also elute along
the nitrocellulose strip.
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Figure 4.5: Assessment of the binding kinetics between direct wick and the plate im-
munoassay format, both performed under direct wick conditions (4 mins at room tem-
perature). A) shows the fluorescent images obtained from the Optical Breadboard Imag-
ing Device (EG Technology) of the test strips. Exposure = 1 s. Conditions are tested
with 0 µg ml-1 and 10 µg ml-1 TNT. Test strips have a BSA-TNT concentration of 5 µg
ml-1. B) shows the corresponding fluorescent readings from the ESEQuant Lateral Flow
Reader of the control and test lines of the test strips, with 0 µg ml-1 (blue, dashed bars)
and 10 µg ml-1 (red, solid bars). C) shows the plate immunoassay results performed
under direct wick conditions, i.e., adding a premixed solution to the BSA-TNT coated
wells (0.5, 1, 2 or 5 µg ml-1 of BSA-TNT) for 4 mins at room temperature. Each con-
dition was tested with 0 µg ml-1 (blue, dashed bars) or 10 µg ml-1 (red, solid bars) of
TNT. Error bars representing standard deviation, n=3.
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For the results shown in Figure 4.5c, the plate contained wells coated with differ-
ent BSA-TNT concentrations (0.5, 1, 2 and 5 µg ml-1) because the exact area and
amount of BSA-TNT that interacts with the premixed solution is unknown, and
hence can not be replicated from the plate immunoassay to the direct wick assay.
Therefore, a range of BSA-TNT concentrations were tested. All BSA-TNT con-
centrations on the plate immunoassay demonstrated competition, which suggested
that the loss of sensitivity in the direct wick format may be due to the antibody
being in such excess that it saturates the BSA-TNT test line. Saturation of the
test line is a result from the antibody binding to all the free TNT in solution
and still having sufficient remaining antibody to bind to the sites available (BSA-
TNT) on the test line, giving a high fluorescence signal. Hence, no competition
will be observed. This can be resolved by increasing the BSA-TNT concentration
in the test line on the test strips, so that the antibody is no longer in such excess.
Another option is to lower the antibody concentration, however, this will result
in loss of fluorescent signal. Therefore, a range of BSA-TNT concentrations were
tested which include: 10, 50, 100, 200 and 400 µg ml-1. The results are shown in
Figure 4.6. As can be seen from the images in Figure 4.6a, all BSA-TNT condi-
tions showed at least one test strip showing competition. There was a statistically
significant decrease in fluorescence signal of the test line, measured with the ES-
EQuant Lateral Flow Reader, at BSA-TNT concentrations at 10, 100 and 400 µg
ml-1 (Figure 4.6b). The variability from the results is likely to be from the direct
wick format which can have an uneven flow and loss of solution to the surrounding
material, i.e., the 2 ml tube. A cassette is employed in the fully assembled, LFIA
format, which is designed to direct the flow of the solution so that neither sample
nor antibody are lost to the surrounding material. Therefore, variability of the
test and control line fluorescent signals should be reduced when using the LFIA
format.
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Figure 4.6: Assessment of increased BSA-TNT concentrations to improve sensitivity of
direct wick assay format. The fluorescent images of the test strips obtained using an
Optical Breadboard Imaging Device (EG Technology) are shown in (a). Exposure = 1
s. Conditions were tested with 0 µg ml-1 (-) and 10 µg ml-1 (+) of TNT. BSA-TNT
concentrations tested were 10, 50, 100, 200 and 400 µg ml-1. The corresponding readings
(obtained using the ESEQuant Lateral Flow Reader) of the test lines on the test strips
from (a) are shown in (b). Error bars representing standard deviation, n=3.
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The optimal condition for the results shown in Figure 4.6 were the strips de-
posited with 10 µg ml-1 of BSA-TNT, because there was complete obliteration of
the test line signal, seen in both the fluorescent images (obtained with the Opti-
cal Breadboard Imaging Device, EG Technology) and the readings of the test line
(measured with the Qiagen ESEQuant Lateral Flow Reader) of the test strips.
Therefore, test strips were deposited with 10 µg ml-1 of BSA-TNT and tested with
a range of TNT concentrations to establish the sensitivity of the assay. The re-
sults are shown in Figure 4.7. It is clear from both the fluorescent images (Figure
4.7a) and ESEQuant readings (Figure 4.8b) that there was high variability with
the test line fluorescence signals between repeats of the same TNT concentration.
At each TNT concentration from 0.63 to 10 µg ml-1, there are test strips which
show competition, i.e., loss of fluorescence signal, and strips that do not. This
can be seen from the loss of test line fluorescent intensity in the images in Figure
4.7a. As stated previously, from observations when performing the direct wick, it
is likely that the lack of consistency may be due to loss of liquid to the underneath
of the test strip and surrounding tube. This results in insufficient and inefficient
movement of the solution through the test strip. Inefficient movement of the
premixed solution through the test strip could result in lower concentrations of
antibody reaching the test and control lines. It is important to note that ineffi-
cient movement of the solution through the test strip did not necessarily result
in the loss of fluorescence signal at the test line. Hence, those test strips which
demonstrate competition are not a result of a loss of solution and reduced anti-
body concentrations reaching the test lines. To reduce variability, the competitive
TNT immunoassay was tested in the LFIA format.
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Figure 4.7: Measurement of the sensitivity of the TNT assay using a range of TNT
concentrations (0-10 µg ml-1). The fluorescent images obtained using an Optical Bread-
board Imaging Device (EG Technology) of the test strips are shown in (a). Exposure =
1 s. The corresponding fluorescent readings (measured on the Qiagen ESEQuant Lateral
Flow Reader) of the control (blue, dashed line) and test (red, solid line) lines of the test
strips are shown in (b). Error bars representing standard deviation, n=3.
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4.3.2 LFIA Studies
The LFIA format was used with the aim to reduce the variability issues that arose
from the direct wick method. In the LFIA, the materials are enclosed within a
cassette and are assembled so that the flow is directed through the system to
prevent loss of solution. The results from the LFIA can be seen in Figure 4.8,
and fluorescent images of the test strips were obtained from an Optical Bread-
board Imaging Device (EG Technology) and the fluorescent signals of the test and
control lines were measured in the Qiagen ESEQuant Lateral Flow Reader. Un-
fortunately, neither the fluorescent images nor the readings from the ESEQuant
Lateral Flow Reader demonstrated competition, as there was no significant de-
crease in fluorescence intensity at the test line with increasing levels of TNT. This
could be due to a number of reasons. Firstly, sensitivity may have been lost due
to the addition of different materials (sample pad and conjugate pad), and larger
volumes of solubilisation buffer used in the LFIA, compared to the direct wick
method. This would mean that the BSA-TNT and anti-TNT antibody concen-
trations may need further optimisation. Secondly, it is important to remember
the stages involved in the LFIA system to understand the problems which may
arise. The sample containing TNT is deposited onto the sample pad. The solution
wicks along the sample pad, solubilising the TNT. The solution containing the
TNT then moves into the conjugate pad, which contains the anti-TNT antibody.
As the solution passes through the conjugate pad, it solubilises the anti-TNT an-
tibody. The solution which contains the TNT and the anti-TNT antibody moves
onto the test strip, where the anti-TNT antibody and TNT interact. As the so-
lution moves along the test strip, the anti-TNT antibody binds the TNT. As the
solution moves over the test line, any anti-TNT antibody which is not occupied by
TNT can bind to the BSA-TNT. With this in mind, the TNT may be interacting
or binding to the sample pad material, making it more difficult to solubilise the
TNT than the anti-TNT antibody, which could mean that the anti-TNT antibody
and TNT do not have an opportunity to interact before they reach the test line.
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There are different approaches to overcome this problem. Different materials for
the sample pad and conjugate pad could be tested, along with different blocking
solutions, to encourage movement of the TNT through the system. However, one
important finding from the results presented in Figure 4.8 is that both the test
and control lines were observed in the fluorescent images (obtained with an Op-
tical Breadboard Imaging Device) and fluorescent readings (measured with the
Qiagen ESEQuant Lateral Flow Reader) of the test strips. In order for there to
be fluorescent signals detected at the test and control lines, the anti-TNT an-
tibody must have been solubilised by the solubilisation buffer and successfully
wicked along the test strip, suggesting that the cassette design and assembly of
the components enables successful flow of the solution and reagents through the
LFIA system.
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Figure 4.8: Measurement of the sensitivity of the TNT assay with a range of TNT con-
centrations (0-10 µg ml-1). The fluorescent images obtained with an Optical Breadboard
Imaging Device (EG Technology) of the test strips are shown in (a). Exposure = 1
s. The corresponding fluorescent readings (measured with a Qiagen ESEQuant Lateral
Flow Reader) of the control (blue, dashed line) and test (red, solid line) lines of the test
strips are shown in (b). Error bars representing standard deviation, n=3.
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4.4 Conclusions
The research described in this chapter begins with the direct wick experiments.
The optimised conditions were taken from the plate immunoassay (Chapter 3) for
the direct wick experiments. Firstly, it was highlighted that the nitrocellulose test
strip required a blocking step since the antibody-TNT solution was not able to
move through the test strip, as control and test lines were not observed. Therefore,
it was likely that the antibody or TNT were non-specifically binding to the nitro-
cellulose. A range of conditions involving BSA and PVP were tested. It was found
that the optimal conditions, i.e., those conditions which had successful movement
of the solution through the nitrocellulose test strip, were 10 mM phosphate buffer
with either 0.1% BSA, 0.1% PVP or 3% PVP. These conditions all displayed con-
trol lines and had high fluorescent signals. No test lines were observed on any
of the conditions, suggesting that the BSA-TNT concentration was too low for a
signal to be detected. Therefore, the three best blocking conditions were taken
forward for further testing. The BSA-TNT concentration was increased from 1
µg ml-1 to 5 µg ml-1, and a range of TNT concentrations were tested to find the
sensitivity of the assay. Both a test line and control line were observed in all test
strips. However, no decrease in fluorescent signal was observed with increasing
TNT concentration, i.e., no competition. The condition with the lowest back-
ground signal was 10 mM phosphate buffer with 3% PVP, which suggested that
this condition provided the lowest levels of non-specific binding. Therefore, the
optimal blocking conditions selected were 10 mM phosphate buffer with 3% PVP
for all future studies.
The lack of competition observed may have been due to the time and temperature
for which the anti-TNT antibody and TNT interact, which was different between
the direct wick (four minutes at room temperature) and plate immunoassay (one
hour at 37oC). The difference in time and temperature, between the direct wick
and plate immunoassay formats, could affect the binding kinetics of the reaction,
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and hence, account for the lack of sensitivity in the direct wick format. There-
fore, a plate immunoassay was performed alongside a direct wick experiment,
using the same time and temperature conditions that the anti-TNT antibody and
TNT interact at in the direct wick format. The results showed that the plate
immunoassay displayed competition under direct wick conditions, suggesting the
lack of sensitivity in the direct wick was due to binding kinetic differences. There-
fore, different BSA-TNT concentrations were tested on the test strips, ranging
from 10-400 µg ml-1. The optimal conditions were found to be 10 µg ml-1 showing
complete obliteration of the test line signal in the presence of 10 µg ml-1 of TNT.
The sensitivity of the assay was then tested by using a range of TNT concen-
trations. There was a trend with increasing TNT concentration and decreasing
fluorescence signal, however, the results were variable so that there could be no
statistical significant decrease. The high variability was likely to be an error of
the direct wick method, with solution being lost to the tube and inefficient wick-
ing of the solution. Therefore, the optimised conditions were applied to the LFIA.
The LFIA is designed to direct the flow of the solution through the system, reduc-
ing error and the variability of the results. The results from the LFIA did have
reduced variability but no competition of the immunoassay was observed, which
could be because the TNT was not able to move through the different materials
fast enough to interact with the anti-TNT antibody. Hence, there needs to be
further screening of materials used for the sample and conjugate pads; and/or
treatment to the materials.
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Chapter 5
Conclusions and Future Work
5.1 Conclusions
Detection of TNT has been shown in a competitive immunoassay (plate im-
munoassay format) at a limit of detection of around 0.03 µg ml-1. The assay
sensitivity was achieved through optimisation of various components of the im-
munoassay. Firstly, the anti-TNT antibody was labelled with an AF488 dye to
remove the need for a secondary antibody, which reduces the number of steps
required in the assay and consequently reduces error. The moles of dye labelled
to one mole of anti-TNT antibody was optimised, testing a range of ratios that
included: 3:1, 9:1, 11:1 and 13:1. The optimal moles of dye per mole of anti-TNT
antibody was 11-13:1, both providing similar sensitivity. It was clear that as the
number of moles of labelled dye increased, so did the sensitivity of the assay. La-
belling an antibody can result in alterations to the tertiary structure. This could
involve alterations to the binding site of the antibody, which could have either a
positive, neutral or negative affect on the antibody’s ability to recognise the TNT.
In this case, the labelling of the anti-TNT antibody was thought to result in a
positive effect, as sensitivity improved with high moles of dyes labelled per mole
of anti-TNT antibody.
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The next stage of the TNT plate immunoassay optimisation was to ensure the so-
lution used to solubilise the TNT, i.e., the solubilisation buffer, provided optimal
solubilisation of TNT so that it was accessible to the antibody. It was important
to ensure the solubilisation buffer was suitable for the TNT, anti-TNT antibody
and lateral flow immunoassay (LFIA) materials that would be used during this
research. Different compositions of the solubilisation buffer were tested, involv-
ing the addition of methanol; different surfactants (Tween 20 and Tween 80) and
different salt (NaCl) concentrations. The solubilisation buffer which provided the
highest sensitivity (0.03 µg ml-1) was 10 mM phosphate buffer with 40 mM NaCl
and 0.12 mM Tween 20 at pH 7.4. Addition of a dissolved fingerprint was tested
with the optimised conditions to ensure that a fingerprint residue did not interact
with the functioning of the assay. It was shown that the fingerprint did intef-
ere with the sensitivity of the immunoassay, as lower concentration of TNT were
required to inhibit 50% of binding of the BSA-TNT by the anti-TNT antibody.
During development of the LFIA test, a larger sample size to measure the effect
and variability of the fingerprint residue should be studied. If may be neccessary
to screen different anti-TNT antibodies to aim to improve binding specificity for
the TNT by the anti-TNT antibody.
The competitive immunoassay principle relies on competitive binding between
the bound and free form of TNT by the anti-TNT antibody. Lower antibody
concentrations improve assay sensitivity because lower TNT concentrations are
required to occupy the anti-TNT antibody and prevent binding of the antibody
to the BSA-TNT, i.e., competition. However, when the anti-TNT antibody con-
centrations are too low, the fluorescence signal is difficult to detect. Hence, there
is balance between sensitivity and signal. Increasing the BSA-TNT concentra-
tion can provide more molecules for the anti-TNT antibody to bind to, and thus
increase the fluorescence signal. The balance between the anti-TNT antibody
and BSA-TNT needs careful optimisation to provide a sensitive and detectable
assay. The optimal conditions were found to be with the anti-TNT antibody at a
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concentration of 6.25 µg ml-1 and the BSA-TNT at 1 µg ml-1, in the plate assay.
These conditions were taken forward to the direct wick method.
The LFIA (lateral flow immunoassay) test requires different materials and vol-
umes of solutions, as compared to the plate immunoassay. Analytes can interact
with the materials used in the LFIA, which can intefere with the functioning of
the assay. Therefore, the direct wick method was employed first as it only uses
the most basic components of the test, which are the nitrocellulose test strip and
the adsorbent pad. The direct wick method aims to show that the basic principle
of the competitive immunoassay can function in the LFIA format, as well as to
show that the analyte and antibody do not interact with the nitrocellulose. It was
shown that the nitrocellulose required to be blocked before adding the TNT and
anti-TNT antibody as it was difficult for the reagents to move along the test strip,
which may have been due to non-specific binding as the nitrocellulose is known to
bind proteins. The optimal blocking buffer was found to be 10 mM PB with 3%
PVP at pH 7.4. It was then observed that the BSA-TNT concentration was too
low at 1µg ml-1, as a test line was difficult to detect. As the control line produced
a high fluorescence signal, it was thought that the immunoassay was functioning
properly. A range of BSA-TNT concentrations were then tested, and the optimal
concentration selected was 10 µg ml-1. The limit of detection using the direct wick
method was likely to be 0.16 µg ml-1 but was not statistically significant due to
the large variability from the results, shown by the error bars. The variability
was likely to be due to the error in the method of the direct wick assay. It was
observed that there was insufficient wicking of the solubilisation buffer along the
test strip, with some solution being lost to the surrounding tube and resulted in
two out of the three test strips tested demonstrating competition at 2.5 µg ml-1.
However, competition was observed with all three repeats for the lower TNT con-
centration of 0.63 µg ml-1. As the lack of consistency may be due to the direct
wick method, the TNT competitive immunoassay was taken forward to be tested
in the LFIA.
105
The LFIA aims to reduce inconsistency as the test is designed to direct the flow
of the solution and reagents through the system. Although reduced variability
was demonstrated in the LFIA, suggested by the reduced standard deviation,
competition was not observed with increasing concentrations of TNT. As stated
previously, the TNT analyte could interact with the different materials and com-
ponents used in the LFIA, such as the sample pad and the conjugate pad. As a
control and test line were both observed, the anti-TNT antibody clearly moved
through the test as expected. However, the TNT and anti-TNT antibody may
not have come into contact with each other, which would mean that the TNT was
more difficult to solubilise after deposition on the Fusion 5 sample pad.
5.2 Future Work
There would be a number of studies that would be completed to obtain a working
LFIA. Firstly, different BSA-TNT and anti-TNT antibody concentrations would
be tested to see if the sensitivity of the assay could be improved. The LFIA
requires larger volumes of solubilisation buffer to move through the system, as
there is a larger distance for the buffer to travel, and more components compared
to the direct wick assay. Although the anti-TNT antibody and TNT would in-
teract for the same distance in the direct wick assay and the LFIA, i.e., along
the test strip length, more solubilisation buffer is required as the solubilisation
buffer must travel along the sample pad and conjugate pad before reaching the
test strip. Therefore, the TNT and anti-TNT antibody may become more dilute
in the LFIA method, as the LFIA requires a larger volume of solubilisation buffer
than the direct wick method. The anti-TNT antibody and BSA-TNT concentra-
tion could be tested at a range of concentrations to find optimal sensitivity. It
is also possible that the anti-TNT antibody and TNT interact with the materi-
als in the LFIA, such as the sample pad or conjugate pad, which could result in
the antibody or TNT being more difficult to solubilise in the solubilisation buffer
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and lower the concentration of the reagents passing through the system. Two ap-
proaches could be taken to overcome the problem of efficient TNT solubilisation.
Firstly, the sample pad and conjugate pad could be tested with different blocking
conditions to improve the movement of the TNT and anti-TNT antibody through
the system. Secondly, a range of materials could be tested for use as the sample
pad or conjugate pad, to assess whether a different material could be more easily
solubilised than from the current material (Fusion 5). If these conditions resulted
in a functioning and detectable LFIA, volunteer fingerprints would be tested to
determine whether TNT residue can be detected.
Once a functioning LFIA test for the detection of TNT has been developed, the
LFIA could be applied to different explosive materials. The LFIA test developed
in this research is based on the high affinity and highly specific interaction be-
tween an antibody and its complimentary analyte. Therefore, the LFIA test could
be applied for use in the detection of other explosive materials, such as RDX and
PETN, as anti-RDX and anti-PETN antibodies are available.
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